https://curecurrent.com/trials/study-of-immune-cells-in-obese-patients-with-type-2-diabetes-mellitus-treated-with-liraglutide-22001https://curecurrent.com/trials/tailored-support-for-type-2-diabetes-patients-with-an-acute-coronary-event-after-discharge-from-hospital-22002https://curecurrent.com/trials/evaluate-efficacy-and-safety-in-japanese-subjects-with-type-2-diabetes-mellitus-22003https://curecurrent.com/trials/a-study-to-compare-insulin-pump-with-conventional-treatment-in-type-2-diabetes-22004https://curecurrent.com/trials/platinum-program-a-feasibility-study-on-a-train-the-trainer-course-on-peer-support-for-people-with-type-2-diabetes-22005https://curecurrent.com/trials/nurse-led-reminder-program-for-therapy-adherence-clinical-outcomes-and-trust-in-nurses-in-diabetic-patients-22006https://curecurrent.com/trials/lifestyle-intervention-for-pakistani-women-in-oslo-22007https://curecurrent.com/trials/motivational-interviewing-to-promote-maintenance-of-physical-activity-in-people-with-type-2-diabetes-22008https://curecurrent.com/trials/dose-response-effect-of-whey-protein-consumed-as-pre-meal-on-postprandial-lipaemia-in-subjects-with-metabolic-syndrome-22009https://curecurrent.com/trials/effect-of-integrated-ckd-care-program-in-early-diabetic-nephropathy-in-primary-health-care-setting-22010https://curecurrent.com/trials/eslicarbazepine-acetate-as-therapy-in-diabetic-neuropathic-pain-22011https://curecurrent.com/trials/after-discharge-management-of-low-income-frail-elderly-22012https://curecurrent.com/trials/post-extraction-wound-healing-in-patients-with-type-2-diabetes-22013https://curecurrent.com/trials/safety-and-effectiveness-study-of-insulin-glargine-lantus-initiation-and-titration-in-patients-with-type-2-diabetes-22014https://curecurrent.com/trials/dietary-intervention-replacing-carbohydrate-with-protein-and-fat-has-greater-effect-on-peripheral-blood-mononuclear-cell-22015https://curecurrent.com/trials/a-prospective-observational-study-to-assess-and-evaluate-the-use-of-glucophage-xr-therapy-in-the-management-of-patients-22016https://curecurrent.com/trials/comparison-between-apdt-and-systemic-doxycycline-on-non-surgical-periodontal-therapy-in-type-2-diabetics-22017https://curecurrent.com/trials/a-study-of-ly3108743-in-healthy-participants-and-participants-with-type-2-diabetes-22018https://curecurrent.com/trials/pharmacokinetics-pharmacodynamics-safety-and-tolerability-of-bi-10773-in-type-ii-diabetes-patients-with-different-degree-22019https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-a-r256918-in-patients-with-type-2-diabetes-22020https://curecurrent.com/trials/pathophysiological-implications-of-the-incretin-hormones-in-patients-with-liver-disease-with-and-without-diabetes-22021https://curecurrent.com/trials/comparison-of-repaglinide-and-gliclazide-in-chinese-subjects-with-type-2-diabetes-never-received-oral-antidiabetic-drug-22022https://curecurrent.com/trials/comprehensive-analyses-of-multidetector-row-cardiac-computed-tomography-data-in-koreans-22023https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-bi-1356-bs-in-patients-with-type-2-diabetes-22024https://curecurrent.com/trials/diabetes-mellitus-after-intensive-care-admission-22025https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-bi-1356-bs-as-tablet-in-patients-with-type-2-diabetes-22026https://curecurrent.com/trials/efficacy-and-safety-of-bi-1356-bs-linagliptin-in-combination-with-metformin-in-patients-with-type2-diabetes-22027https://curecurrent.com/trials/diabetes-treatment-with-glucobay-in-combination-with-metformin-22028https://curecurrent.com/trials/calorimetry-insulin-resistance-and-energy-metabolism-study-to-understand-the-risk-of-obesity-in-kidney-transplanted-pati-22029https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-multiple-rising-doses-of-bi-10773-tablets-22030https://curecurrent.com/trials/phase-4-study-to-assess-the-effect-of-bisoprolol-on-glycemic-level-in-type-ii-diabetic-subjects-with-suboptimal-blood-pr-22031https://curecurrent.com/trials/closed-loop-control-of-glucose-levels-artificial-pancreas-for-24-hours-in-adults-and-adolescents-with-type-1-diabetes-22032https://curecurrent.com/trials/effects-of-intralipid-versus-olive-oil-infusions-on-endothelial-function-immune-function-inflammatory-markers-22033https://curecurrent.com/trials/young-toe-brachial-index-assessment-22034https://curecurrent.com/trials/egg-effects-on-atherogenic-dyslipidemias-glucose-metabolism-and-inflammation-in-diabetic-subjects-22035https://curecurrent.com/trials/drug-drug-interaction-study-lobeglitazone-warfarin-22036https://curecurrent.com/trials/type-ii-diabetes-mellitus-in-patients-exposed-to-pravastatin-and-paroxetine-22037https://curecurrent.com/trials/a-study-to-investigate-the-benefits-of-the-early-detection-and-intensive-treatment-of-type-2-diabetes-22038https://curecurrent.com/trials/gut-microbiota-in-obesity-and-diabetes-22039https://curecurrent.com/trials/reandron-in-diabetic-men-witn-low-testosterone-level-22040https://curecurrent.com/trials/endobarrier-treatment-in-obese-subjects-with-t2dm-22041https://curecurrent.com/trials/investigation-on-safety-tolerability-and-pharmacokinetics-of-multiple-doses-of-nnc0113-0987-in-an-oral-formulation-in-he-22042https://curecurrent.com/trials/the-effect-of-linagliptin-bi-1356-on-24h-glucose-control-and-various-biomarkers-in-type-2-diabetic-patients-22043https://curecurrent.com/trials/linagliptin-2-5-mg-twice-daily-versus-5-mg-once-daily-as-add-on-therapy-to-twice-daily-metformin-in-type-2-diabetes-22044https://curecurrent.com/trials/an-observational-study-investigating-the-safety-and-effectiveness-of-repaglinide-in-chinese-patients-22045https://curecurrent.com/trials/glycemic-responses-to-majia-pomelos-in-type-2-diabetic-patients-22046https://curecurrent.com/trials/a-randomised-single-centre-double-blind-two-period-cross-over-trial-in-healthy-subjects-investigating-the-bioequivalence-22047https://curecurrent.com/trials/carotid-atherosclerosis-in-newly-diagnosed-type-2-individuals-22048https://curecurrent.com/trials/leptin-and-visfatin-in-diabetic-patients-with-periodontitis-before-and-after-periodontal-therapy-22049https://curecurrent.com/trials/influence-of-vasculary-inflammation-on-development-of-diabetes-22050https://curecurrent.com/trials/effect-of-glucagon-like-peptide-1-glp-1-on-microvascular-myocardial-function-in-patients-with-type-2-diabetes-22051https://curecurrent.com/trials/brown-adipose-tissue-and-body-mass-index-22052https://curecurrent.com/trials/effectiveness-and-safety-of-adding-compound-preparation-of-pioglitazone-and-metformin-for-type-2-diabetic-patients-22053https://curecurrent.com/trials/a-retrospective-study-to-assess-the-outcome-after-surgical-reconstruction-of-the-midfoot-with-the-midfoot-fusion-bolt-in-22054https://curecurrent.com/trials/an-observational-study-of-insulin-aspart-and-if-necessary-insulin-levemir-flexpen-in-the-evening-or-at-bedtime-22055https://curecurrent.com/trials/anesthesia-with-epinephrine-in-diabetes-patients-is-safe-and-effective-22056https://curecurrent.com/trials/a-survey-to-evaluate-diabetes-management-control-chronic-complications-psychosocial-aspects-of-diabetic-subjects-in-indo-22057https://curecurrent.com/trials/observational-study-to-evaluate-the-safety-and-efficacy-of-novomix-70-in-type-2-diabetes-22058https://curecurrent.com/trials/effect-of-supplementary-vitamin-d-in-patients-with-diabetes-mellitus-and-pulmonary-tuberculosis-22059https://curecurrent.com/trials/preventing-hypoglycemia-22060https://curecurrent.com/trials/investigation-on-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-multiple-doses-of-a-long-acting-glp-1-anal-22061https://curecurrent.com/trials/a-study-to-assess-the-effect-of-creon-on-pancreatic-exocrine-insufficiency-in-subjects-with-diabetes-mellitus-type-2-22062https://curecurrent.com/trials/feasibility-study-of-a-portable-artificial-pancreas-system-in-type-1-diabetes-mellitus-t1dm-padova-22063https://curecurrent.com/trials/glucophage-xr-observational-study-22064https://curecurrent.com/trials/saxagliptin-and-atherosclerosis-22065https://curecurrent.com/trials/12-weeks-treatment-with-3-different-doses-of-bi-10773-in-type-2-diabetic-patients-22066https://curecurrent.com/trials/taiwan-diabesity-study-comparison-with-mild-obese-t2dm-patients-who-under-metabolic-surgery-22067https://curecurrent.com/trials/pharmacokinetics-pharmacodynamics-safety-and-tolerability-of-empagliflozin-in-chinese-female-and-male-patients-with-type-22068https://curecurrent.com/trials/empagliflozin-bi-10773-dose-finder-study-in-japanese-patients-with-type-2-diabetes-mellitus-22069https://curecurrent.com/trials/effect-of-pioglitazone-versus-metformin-on-bone-health-in-postmenopausal-women-with-type-2-diabetes-22070https://curecurrent.com/trials/safety-and-efficacy-of-empagliflozin-bi-10773-in-type-1-diabetes-mellitus-patients-with-or-without-renal-hyperfiltration-22071https://curecurrent.com/trials/empagliflozin-bi-10773-comprehensive-add-on-study-in-japanese-subjects-with-type-2-diabetes-mellitus-22072https://curecurrent.com/trials/safety-of-continuing-metformin-in-diabetic-patients-with-normal-kidney-function-receiving-contrast-media-22073https://curecurrent.com/trials/comparing-insulin-aspart-with-fast-acting-insulin-human-in-subjects-with-type-1-diabetes-22074https://curecurrent.com/trials/myo-inositol-administration-in-gestational-diabetes-22075https://curecurrent.com/trials/safety-and-effectiveness-of-low-molecular-weight-sulfated-dextran-in-islet-transplantation-after-kidney-transplant-22076https://curecurrent.com/trials/a-trial-investigating-the-relationship-between-pharmacodynamic-and-interstitial-concentration-for-insulin-detemir-and-hu-22077https://curecurrent.com/trials/pst-linkage-based-analysis-in-the-family-of-more-than-two-members-with-type-1-diabetes-in-taiwan-22078https://curecurrent.com/trials/evaluation-of-group-health-teaching-with-video-in-diabetic-patients-22079https://curecurrent.com/trials/effects-of-mixed-herbs-on-blood-glucose-and-lipid-profile-in-t2dm-patients-22080https://curecurrent.com/trials/comparison-of-a-new-formulation-of-insulin-glargine-with-lantus-in-japanese-patients-with-type-1-diabetes-mellitus-22081https://curecurrent.com/trials/diabetic-retinopathy-candesartan-trials-22082https://curecurrent.com/trials/be-study-of-the-fixed-dose-combination-of-5-mg-saxagliptin-and-500-mg-metformin-hcl-xr-tablet-relative-to-a-5-mg-saxagli-22083https://curecurrent.com/trials/comparison-of-a-new-formulation-of-insulin-glargine-with-lantus-both-in-combination-with-oral-antihyperglycemic-drug-s-i-22084https://curecurrent.com/trials/dexmedetomidine-influence-on-the-level-of-perioperative-blood-glucose-and-insulin-of-elderly-diabetes-patients-22085https://curecurrent.com/trials/diabetic-retinopathy-candesartan-trials-22086https://curecurrent.com/trials/characterization-of-high-density-lipoprotein-hdl-in-type-2-diabetes-t2d-after-fenofibrate-or-niacin-treatment-22087https://curecurrent.com/trials/effects-of-sitagliptin-on-type-2-diabetes-mellitus-patients-on-treatment-with-metformin-and-insulin-22088https://curecurrent.com/trials/cystic-fibrosis-related-diabetes-22089https://curecurrent.com/trials/heritage-study-genetics-exercise-and-risk-factors-22090https://curecurrent.com/trials/a-cross-sectional-survey-to-evaluate-diabetes-management-control-complications-psychosocial-aspects-of-patients-with-typ-22091https://curecurrent.com/trials/ubiquitous-healthcare-for-elderly-patients-with-type-2-diabetes-mellitus-22092https://curecurrent.com/trials/effect-of-vildagliptin-in-type-2-diabetes-treated-with-sulphonylurea-and-metformin-22093https://curecurrent.com/trials/fluid-dairy-products-consumed-before-and-within-a-pizza-meal-on-glycemic-response-food-intake-and-satiety-in-children-22094https://curecurrent.com/trials/the-effect-of-extract-of-green-tea-on-obese-women-and-obese-related-hormone-peptides-22095https://curecurrent.com/trials/pancreatic-islet-mass-in-pregnancy-in-type-1-diabetes-22096https://curecurrent.com/trials/is-insulin-resistance-and-or-glucose-intolerance-pathogenetic-in-the-development-of-a-reduced-incretin-effect-22097https://curecurrent.com/trials/the-initial-assessment-of-daily-insulin-dose-in-newly-diagnosed-type-2-diabetes-22098https://curecurrent.com/trials/copeptin-as-a-diagnostic-marker-in-the-management-of-neurosurgical-patients-with-disturbance-of-water-homeostasis-22099https://curecurrent.com/trials/copeptin-changes-after-food-intake-22100https://curecurrent.com/trials/effects-of-legume-consumption-on-adiponectin-and-inflammatory-markers-among-adults-22101https://curecurrent.com/trials/action-in-diabetes-and-vascular-disease-preterax-and-diamicron-mr-controlled-evaluation-post-trial-observational-study-22102https://curecurrent.com/trials/efficacy-and-safety-of-insuman-basal-comb-rapid-in-patients-with-type-2-diabetes-22103https://curecurrent.com/trials/duloxetine-in-patients-with-diabetic-in-peripheral-neuropathic-pain-with-or-without-co-morbid-major-depressive-disorder-22104https://curecurrent.com/trials/psychological-aspects-and-insulin-pump-therapy-22105https://curecurrent.com/trials/efficacy-of-dexmedetomidine-in-preventing-contrast-induced-nephropathy-22106https://curecurrent.com/trials/effect-of-microvesicles-and-exosomes-therapy-on-cell-mass-in-type-i-diabetes-mellitus-t1dm-22107https://curecurrent.com/trials/evaluation-of-vildagliptin-galvus-as-add-on-to-insulin-in-new-onset-type-1-diabetes-mellitus-22108https://curecurrent.com/trials/diabetic-retinopathy-candesartan-trials-22109https://curecurrent.com/trials/efficacy-and-safety-of-cwp-0403-compared-to-sitagliptin-in-patients-with-type-2-diabetes-mellitus-insufficiently-control-22110https://curecurrent.com/trials/treatment-of-type-2-diabetes-with-linagliptin-2-5-mg-bid-metformin-500-or-1000-mg-bid-and-metformin-1000-mg-bid-22111https://curecurrent.com/trials/interventricular-cardiac-septal-thickness-in-fetus-of-diabetic-mother-correlated-to-postnatal-outcome-22112https://curecurrent.com/trials/home-and-school-visits-intervention-for-children-with-dm-type-1-22113https://curecurrent.com/trials/continuous-glucose-monitoring-and-metabolic-control-in-children-with-type-1-diabetes-22114https://curecurrent.com/trials/dietary-supplement-of-lehel-for-the-patients-with-type-2-diabetes-22115https://curecurrent.com/trials/metronidazole-and-amoxicillin-for-the-treatment-of-type-2-diabetic-subjects-with-periodontitis-22116https://curecurrent.com/trials/beta-cell-rescue-in-new-onset-type-1-diabetes-with-efalizumab-22117https://curecurrent.com/trials/can-resveratrol-improve-insulin-sensitivity-and-preserve-beta-cell-function-following-gestational-diabetes-22118https://curecurrent.com/trials/calcineurin-inhibitor-cni-free-immunosuppressive-regimen-in-t1d-patients-receiving-islet-transplantation-22119https://curecurrent.com/trials/a-efficacy-safety-and-tolerability-study-of-canagliflozin-in-patients-with-type-2-diabetes-mellitus-with-inadequate-glyc-22120https://curecurrent.com/trials/efficacy-and-safety-of-the-fixed-dose-combination-of-glimepiride-metformin-in-type-2-diabetic-patients-inadequately-cont-22121https://curecurrent.com/trials/the-effect-of-spironolactone-on-blood-pressure-in-type-2-diabetics-with-resistant-hypertension-22122https://curecurrent.com/trials/evaluation-of-fixed-dose-combination-of-glimepiride-and-metformin-in-chinese-type-2-diabetes-patients-inadequately-contr-22123https://curecurrent.com/trials/evaluation-of-the-educational-program-of-diabetes-mellitus-focus-on-empowerment-22124https://curecurrent.com/trials/levemir-body-composition-and-energy-metabolism-22125https://curecurrent.com/trials/ppp-botnia-exercise-intervention-study-22126https://curecurrent.com/trials/effects-of-vildagliptin-versus-glibenclamide-on-glycemia-after-exercise-in-patients-with-type-2-diabetes-22127https://curecurrent.com/trials/regulation-of-intestinal-and-hepatic-lipoprotein-secretion-by-resveratrol-22128https://curecurrent.com/trials/the-effect-of-the-use-of-computer-game-my-diabetic-friend-in-children-with-type-1-diabetes-22129https://curecurrent.com/trials/statins-for-oxidative-stress-and-mitochondrial-function-in-diabetic-polyneuropathy-22130https://curecurrent.com/trials/inflammatory-aspects-of-glucose-in-hyperlipidemia-and-diabetes-22131https://curecurrent.com/trials/effect-on-beta-cell-function-and-glycaemic-control-after-insulin-and-exenatide-sequential-therapy-22132https://curecurrent.com/trials/michael-method-fulfilling-individual-potential-to-attain-excellence-as-a-tool-for-improving-metabolic-control-and-qualit-22133https://curecurrent.com/trials/4-weeks-treatment-of-type-ii-diabetic-patients-with-bi-44847-22134https://curecurrent.com/trials/bioflow-iii-romania-satellite-registry-22135https://curecurrent.com/trials/investigation-on-safety-tolerability-and-pharmacokinetics-of-single-and-multiple-doses-of-a-long-acting-glp-1-analogue-s-22136https://curecurrent.com/trials/percutaneous-electric-neurostimulation-of-dermatome-t7-improves-glycemic-profile-in-obese-and-typo-2-diabetic-patients-22137https://curecurrent.com/trials/antibiotic-treatment-duration-for-non-surgically-treated-diabetic-foot-osteomyelitis-22138https://curecurrent.com/trials/mechanical-chemical-gingival-therapy-in-diabetics-and-or-obese-22139https://curecurrent.com/trials/amiloride-for-resistant-hypertension-22140https://curecurrent.com/trials/selective-immunotargeting-of-pathogenic-cd8-t-cells-of-type-1-diabetes-patients-22141https://curecurrent.com/trials/impact-of-peer-support-on-diabetes-in-china-22142https://curecurrent.com/trials/effects-of-glp-1-receptor-agonist-on-fat-redistribution-and-inflammatory-status-22143https://curecurrent.com/trials/long-term-study-of-alogliptin-as-an-add-on-to-rapid-acting-insulin-secretagogues-in-type-2-diabetes-22144https://curecurrent.com/trials/a-community-pharmacy-based-program-to-improve-management-of-diabetes-22145https://curecurrent.com/trials/mitochondrial-nt3243-a-g-mutation-in-taiwan-22146https://curecurrent.com/trials/residual-gastric-volume-in-morbidly-obesa-diabetics-a-comparison-of-3-hour-versus-hour-fasting-22147https://curecurrent.com/trials/acute-dose-response-of-korean-white-ginseng-in-metabolic-syndrome-or-type-2-diabetes-22148https://curecurrent.com/trials/high-blood-pressure-and-sleep-apnea-in-diabetic-macular-edema-22149https://curecurrent.com/trials/ovarian-ageing-in-type-1-diabetes-mellitus-22150https://curecurrent.com/trials/orthogonal-polarisation-study-in-young-elderly-and-type-2-diabetics-22151https://curecurrent.com/trials/assessment-of-the-efficacy-and-safety-of-a-new-wound-dressing-in-the-local-treatment-of-diabetic-foot-ulcers-22152https://curecurrent.com/trials/closed-loop-control-of-glucose-levels-after-meal-intake-in-adults-with-type-1-diabetes-22153https://curecurrent.com/trials/efficacy-of-cacipliq20-on-diabetic-ulcers-in-patients-wearing-an-nonremovable-windowed-fiberglass-cast-boot-22154https://curecurrent.com/trials/effect-of-linagliptin-on-insulin-sensitivity-and-pancreatic-beta-cell-function-in-patients-with-type-2-diabetes-mellitus-22155https://curecurrent.com/trials/safety-and-efficacy-study-of-urokinase-for-the-treatment-of-diabetic-foot-syndrome-and-critical-limb-ischemia-22156https://curecurrent.com/trials/register-for-patients-with-diabetic-foot-syndrome-and-critical-limb-ischemia-22157https://curecurrent.com/trials/phenotyping-diabetic-retinopathy-22158https://curecurrent.com/trials/impact-of-cardiac-magnetic-resonance-imaging-on-endothelial-function-in-type-2-diabetes-22159https://curecurrent.com/trials/validation-of-a-predictive-model-to-estimate-the-risk-of-conversion-to-clinically-significant-macular-edema-and-or-visio-22160https://curecurrent.com/trials/closed-loop-insulin-therapy-in-type-1-diabetics-based-on-blood-microdialysis-online-sensors-and-an-empc-algorithm-22161https://curecurrent.com/trials/a-study-of-postprandial-hyperglycemia-in-participants-with-type-2-diabetes-22162https://curecurrent.com/trials/dose-finding-study-of-lik066-compared-with-placebo-or-sitagliptin-to-evaluate-change-in-hba1c-in-patients-with-diabetes-22163https://curecurrent.com/trials/vildagliptin-add-on-to-glimepiride-versus-placebo-added-to-glimepiride-in-type-2-diabetes-22164https://curecurrent.com/trials/effect-of-vitamin-d-supplementation-on-the-metabolic-control-and-body-composition-of-type-2-diabetes-subjects-in-ajman-u-22165https://curecurrent.com/trials/ataglu-study-of-glucose-metabolism-in-hiv-positive-patients-that-switch-from-another-protease-inhibitor-to-atazanavir-22166https://curecurrent.com/trials/the-effects-of-rvx000222-on-glucose-metabolism-in-individuals-with-pre-diabetes-22167https://curecurrent.com/trials/dyslipidemia-and-risk-of-cardiovascular-disease-in-diabetic-men-and-women-22168https://curecurrent.com/trials/efficacy-and-safety-of-insulin-glargine-versus-neutral-protamine-hagedorn-nph-insulin-in-children-with-type-1-diabetes-a-22169https://curecurrent.com/trials/whey-protein-on-posprandial-glucose-insulin-glp-1-gip-and-dpp4-in-type-2-diabetes-22170https://curecurrent.com/trials/effects-of-coffee-consumption-on-glucose-metabolism-22171https://curecurrent.com/trials/bi-1356-linagliptin-in-combination-with-metformin-and-a-sulphonylurea-in-type-2-diabetes-22172https://curecurrent.com/trials/comparison-of-the-bioavailability-of-metformin-between-medium-dose-linagliptin-metformin-tablets-and-medium-dose-glucoph-22173https://curecurrent.com/trials/comprehensive-add-on-study-in-japan-22174https://curecurrent.com/trials/biomarkers-in-seizure-to-predict-recurrence-and-severe-outcomes-22175https://curecurrent.com/trials/inositol-stereoisomers-to-treat-gestational-diabetes-22176https://curecurrent.com/trials/genetic-variation-in-the-transporters-and-hypoglycemic-agents-22177https://curecurrent.com/trials/comparison-of-new-onset-diabetes-after-transplantation-between-two-steroid-withdrawal-group-with-cellcept-22178https://curecurrent.com/trials/evaluation-of-an-intervention-based-on-cell-phones-22179https://curecurrent.com/trials/cost-effectiveness-of-slimmer-diabetes-prevention-intervention-22180https://curecurrent.com/trials/technological-rehabilitation-of-distal-sensorimotor-polyneuropathy-in-diabetic-patients-22181https://curecurrent.com/trials/effect-of-physical-exercise-on-endothelial-function-in-patients-with-type-2-diabetes-mellitus-22182https://curecurrent.com/trials/alimentation-and-diabetes-in-lanzarote-adilan-a-pilot-trial-22183https://curecurrent.com/trials/intraperitoneal-vs-subcutaneous-insulin-administration-in-type-1-diabetes-mellitus-22184https://curecurrent.com/trials/oral-antidiabetic-agents-in-pregnancy-22185https://curecurrent.com/trials/efficacy-safety-and-satisfaction-of-the-new-pen-needle-33-gauge-x-4-mm-22186https://curecurrent.com/trials/impact-of-blood-glucose-at-the-first-trimester-of-pregnant-women-with-gestational-diabetes-on-maternal-and-fetal-outcome-22187https://curecurrent.com/trials/basal-bolus-therapy-in-patients-with-type-1-diabetes-mellitus-22188https://curecurrent.com/trials/a-comparison-of-islet-cell-transplantation-with-medical-therapy-for-the-treatment-of-diabetic-eye-disease-22189https://curecurrent.com/trials/macronutrients-and-gut-hormone-secretion-22190https://curecurrent.com/trials/trial-comparing-care-in-multiple-clinics-versus-care-in-a-cardiac-diabetes-and-kidney-care-clinic-22191https://curecurrent.com/trials/phase-iii-trial-to-evaluate-the-efficacy-and-safety-of-gemigliptin-50mg-qd-added-to-ongoing-glimepiride-as-fix-dose-comb-22192https://curecurrent.com/trials/mortality-follow-up-and-analyses-of-men-in-the-mrfit-22193https://curecurrent.com/trials/dipeptidyl-peptidase-4-inhibitors-and-alpha-cell-recovery-22194https://curecurrent.com/trials/quantitative-and-qualitative-mri-study-of-steatosis-in-patients-with-metabolic-steatopathy-22195https://curecurrent.com/trials/metabolic-effects-of-antipsychotic-substitution-in-children-22196https://curecurrent.com/trials/chinese-community-smoking-cessation-project-22197https://curecurrent.com/trials/biomarkers-of-oxidative-stress-in-look-ahead-ancillary-to-look-ahead-22198https://curecurrent.com/trials/mechanisms-behind-antidiabetic-effects-by-gastric-by-pass-22199https://curecurrent.com/trials/effect-of-autonomic-neuropathy-on-the-efficacy-of-a-dpp-iv-inhibitor-galvus-therapy-22200https://curecurrent.com/trials/evaluation-of-safety-and-efficacy-of-dapagliflozin-in-subjects-with-type-2-diabetes-who-have-inadequate-glycaemic-contro-22201https://curecurrent.com/trials/comparison-of-pk-after-administration-of-hcp1201-and-co-administration-of-metformin-sr-750mg-and-rosuvastatin-10mg-22202https://curecurrent.com/trials/comparison-of-pk-after-administration-of-hcp1201-and-co-administration-of-metformin-sr-500mg-and-rosuvastatin-10mg-22203https://curecurrent.com/trials/prevention-of-severe-hypoglycaemia-with-hypo-safe-hypoglycaemia-alarm-device-22204https://curecurrent.com/trials/sitagliptin-in-cystic-fibrosis-related-diabetes-22205https://curecurrent.com/trials/preventing-diabetes-in-those-at-risk-by-having-a-facilitator-and-family-doctor-encourage-healthy-activity-and-eating-hab-22206https://curecurrent.com/trials/monocyte-chemoattractant-protein-1-2518a-g-polymorphism-22207https://curecurrent.com/trials/outpatient-nurse-managed-counseling-program-for-patients-with-diabetic-foot-ulceration-a-pilot-study-22208https://curecurrent.com/trials/study-of-the-effects-of-xoma-052-on-insulin-production-in-subjects-with-well-controlled-type-1-diabetes-22209https://curecurrent.com/trials/effects-of-liraglutide-on-kidney-function-in-type-2-diabetic-patients-22210https://curecurrent.com/trials/myo-inositol-in-obese-pregnant-women-22211https://curecurrent.com/trials/treatment-of-hdl-to-reduce-the-incidence-of-vascular-events-hps2-thrive-22212https://curecurrent.com/trials/study-of-ptpn22-c1858t-polymorphism-in-children-and-adolescents-of-greek-origin-with-t1dm-22213https://curecurrent.com/trials/efficacy-study-of-pioglitazone-and-metformin-and-association-between-pioglitazone-response-and-peroxisome-proliferator-a-22214https://curecurrent.com/trials/the-influence-of-health-beliefs-and-uncertainty-on-diabetes-type-ii-patient-compliance-22215https://curecurrent.com/trials/a-human-clinical-trial-evaluating-the-effect-of-mealshape-on-blood-glucose-level-following-consumption-of-standard-meal-22216https://curecurrent.com/trials/the-acute-effect-of-interval-walking-22217https://curecurrent.com/trials/a-spanish-pillbox-app-for-elderly-patients-taking-multiple-medications-22218https://curecurrent.com/trials/absorption-of-insulin-following-subcutaneous-bolus-administration-with-different-bolus-durations-22219https://curecurrent.com/trials/the-cronos-adm-registry-22220https://curecurrent.com/trials/acute-effect-of-intensive-insulin-infusion-on-intestinal-triglyceride-rich-lipoprotein-apob48-metabolism-in-type-2-diabe-22221https://curecurrent.com/trials/influence-of-moderate-exercise-on-blood-glucose-in-type-2-diabetics-and-healthy-controls-22222https://curecurrent.com/trials/nox-e36-in-patients-with-type-2-diabetes-mellitus-and-albuminuria-22223https://curecurrent.com/trials/comparison-of-the-efficacy-and-safety-of-two-insulin-intensification-strategies-22224https://curecurrent.com/trials/pantoprazole-on-insulin-secretion-in-diabetes-22225https://curecurrent.com/trials/heart-failure-in-the-community-22226https://curecurrent.com/trials/glucose-reduction-by-early-acarbose-treatment-in-basal-insulin-22227https://curecurrent.com/trials/umbilical-cord-mesenchymal-stem-cells-and-liraglutide-in-diabetes-mellitus-22228https://curecurrent.com/trials/improving-monitoring-of-patients-receiving-case-management-22229https://curecurrent.com/trials/remission-rates-of-new-type-2-diabetes-with-weight-loss-and-exercise-22230https://curecurrent.com/trials/efficacy-and-safety-of-bi-1356-linagliptin-versus-placebo-in-type-2-diabetic-patients-with-insufficient-glycemic-control-22231https://curecurrent.com/trials/renewing-health-regions-of-europe-working-together-for-health-22232https://curecurrent.com/trials/efficacy-vs-placebo-as-initial-combination-therapy-with-pioglitazone-22233https://curecurrent.com/trials/reading-center-occurence-of-diabetic-macular-edema-in-patients-with-diabetes-mellitus-in-slovak-republic-22234https://curecurrent.com/trials/full-mouth-and-partial-mouth-scaling-and-root-planing-in-type-2-diabetic-subjects-22235https://curecurrent.com/trials/clinical-trial-technology-development-for-the-validation-of-surrogate-prognostic-markers-in-patients-with-diabetic-nephr-22236https://curecurrent.com/trials/the-influence-of-technology-education-and-psychological-support-on-metabolic-control-in-children-with-t1d-22237https://curecurrent.com/trials/efficacy-of-ubiquinone-and-combined-antioxidant-therapy-in-non-proliferative-diabetic-retinopathy-22238https://curecurrent.com/trials/neuropathic-pain-management-22239https://curecurrent.com/trials/diabetes-distress-psychological-well-being-and-family-hardiness-in-parents-of-children-and-adolescents-with-t1d-22240https://curecurrent.com/trials/assessment-of-three-instruments-for-the-non-invasive-measurement-of-arterial-stiffness-22241https://curecurrent.com/trials/effects-of-saxagliptin-on-endothelial-function-22242https://curecurrent.com/trials/cost-effectiveness-of-in-shoe-pressure-measurement-for-therapeutic-shoes-22243https://curecurrent.com/trials/effects-of-xoma-052-on-insulin-production-in-type-1-diabetes-22244https://curecurrent.com/trials/irbesartan-versus-amlodipine-the-obi-study-22245https://curecurrent.com/trials/reversal-of-neuromuscular-blockade-in-diabetic-patients-22246https://curecurrent.com/trials/carbohydrates-to-prevent-hypoglycaemia-during-physical-activity-in-patients-with-type-1-diabetes-22247https://curecurrent.com/trials/accu-chek-aviva-expert-study-does-use-of-a-bolus-advisor-improve-glycemic-control-in-patients-not-achieving-optimal-cont-22248https://curecurrent.com/trials/the-effect-of-lipoic-acid-treatment-in-patient-with-cardiac-autonomic-neuropathy-22249https://curecurrent.com/trials/risk-prediction-in-type-ii-diabetics-with-ischemic-heart-disease-22250https://curecurrent.com/trials/rct-of-sms-for-drivers-with-pre-dm-22251https://curecurrent.com/trials/a-trial-investigating-the-accuracy-and-precision-of-the-bgstar-and-ibgstar-blood-glucose-meter-in-subjects-with-type-1-d-22252https://curecurrent.com/trials/soluble-fibre-enriched-cho-food-study-22253https://curecurrent.com/trials/trial-to-compare-the-relative-pharmacodynamic-properties-of-different-glucagon-dosages-22254https://curecurrent.com/trials/studies-of-pancreatic-islet-mass-by-positron-emission-tomography-pet-22255https://curecurrent.com/trials/treatment-of-patients-with-newly-onset-of-type-1-diabetes-with-mesenchymal-stem-cells-22256https://curecurrent.com/trials/hemodynamic-effects-of-vasopressin-in-early-septic-shock-stage-22257https://curecurrent.com/trials/evaluate-adherence-to-treatment-with-glucophage-sachets-versus-tablets-in-diabetes-type-2-patients-previously-treated-wi-22258https://curecurrent.com/trials/the-copenhagen-insulin-and-metformin-therapy-trial-22259https://curecurrent.com/trials/vasodilatory-and-metabolic-effects-of-glucagon-like-peptide-1-in-periphery-circulation-in-patients-with-and-without-type-22260https://curecurrent.com/trials/acute-exercise-and-pancreatic-endocrine-function-22261https://curecurrent.com/trials/effects-of-dipeptidyl-peptidase-4-dpp-4-inhibition-on-hormonal-responses-to-macronutrient-ingestion-22262https://curecurrent.com/trials/closing-the-loop-in-adults-with-type-1-diabetes-in-the-home-setting-22263https://curecurrent.com/trials/efficacy-and-safety-of-linagliptin-in-elderly-patients-with-type-2-diabetes-22264https://curecurrent.com/trials/safety-and-efficacy-of-linagliptin-bi-1356-plus-metformin-in-type-2-diabetes-factorial-design-22265https://curecurrent.com/trials/study-of-the-effects-of-carbohydrate-counting-22266https://curecurrent.com/trials/remote-monitoring-of-diabetes-in-pregnancy-a-feasibility-study-22267https://curecurrent.com/trials/long-term-study-of-tak-875-22268https://curecurrent.com/trials/japanese-p-iii-vs-voglibose-and-placebo-22269https://curecurrent.com/trials/medical-record-study-on-adverse-events-requiring-a-higher-level-of-care-in-flemish-hospitals-22270https://curecurrent.com/trials/evaluation-of-a-regional-electronic-health-information-exchange-s-clinical-health-record-22271https://curecurrent.com/trials/efficacy-usability-study-of-the-glucotab-system-for-glycaemic-management-in-type-2-diabetic-patients-at-general-wards-22272https://curecurrent.com/trials/comparison-of-metformin-and-repaglinide-monotherapy-in-the-treatment-of-new-onset-type-2-diabetes-mellitus-in-china-22273https://curecurrent.com/trials/a-study-of-xuebi-formula-for-diabetic-peripheral-neuropathy-qi-deficiency-and-blood-stasis-22274https://curecurrent.com/trials/dietary-intervention-in-diabetes-mellitus-didm-intermediate-and-acute-effects-22275https://curecurrent.com/trials/electronically-connected-health-coaching-in-type-2-diabetes-22276https://curecurrent.com/trials/r230c-and-c230c-variants-of-abca1-and-glyburide-response-22277https://curecurrent.com/trials/evaluation-of-the-macular-peripapillary-nerve-fiber-layer-and-choroid-thickness-changes-in-the-gestational-diabetes-mell-22278https://curecurrent.com/trials/study-on-the-efficacy-and-safety-of-jinlida-granules-in-patients-with-inadequately-controlled-type-2-diabetes-and-dyslip-22279https://curecurrent.com/trials/the-healthy-options-feasibility-study-22280https://curecurrent.com/trials/a-phase-2-study-of-tapentadol-extended-release-jns024er-in-japanese-participants-with-chronic-pain-due-to-diabetic-neuro-22281https://curecurrent.com/trials/efficacy-study-of-diazoxide-choline-to-treat-hypertriglyceridemia-22282https://curecurrent.com/trials/effects-of-lifestyle-education-programs-on-diabetes-control-in-rwanda-22283https://curecurrent.com/trials/along-term-study-of-opc-262-in-patients-with-type-2-diabetes-22284https://curecurrent.com/trials/a-phase-3-study-of-opc-262-in-patients-with-type-2-diabetes-22285https://curecurrent.com/trials/a-study-of-opc-262-in-patients-with-type-2-diabetes-22286https://curecurrent.com/trials/role-of-interleukin-1-in-the-regulation-of-muscle-derived-interleukin-6-during-exercise-22287https://curecurrent.com/trials/a-study-of-opc-262-in-patients-with-type-2-diabetes-22288https://curecurrent.com/trials/diabetes-mellitus-a-diagnosis-trial-by-means-of-non-invasive-measurements-22289https://curecurrent.com/trials/almond-intervention-in-type-2-diabetes-mellitus-22290https://curecurrent.com/trials/uptake-of-comprehensive-eye-examination-trial-22291https://curecurrent.com/trials/a-trial-investigating-the-pharmacokinetics-and-pharmacodynamics-of-nnc0123-0000-0338-in-a-tablet-formulation-with-three-22292https://curecurrent.com/trials/counterregulatory-hormone-production-in-adrenal-insufficiency-and-diabetes-type-i-22293https://curecurrent.com/trials/metformin-and-pioglitazone-effects-on-fetuin-a-and-osteoprotegrin-concentrations-in-type-2-diabetes-patients-22294https://curecurrent.com/trials/study-of-betatrophin-levels-in-patients-with-type-2-diabetes-and-gestational-diabetes-and-healthy-subjects-22295https://curecurrent.com/trials/phase-1-sad-and-mad-study-of-ngm282-in-healthy-adult-participants-22296https://curecurrent.com/trials/the-effect-of-concentrated-pomegranate-juice-consumption-on-lipid-profile-and-inflammatory-factors-in-patients-with-type-22297https://curecurrent.com/trials/beta-cell-function-in-pre-type-1-diabetes-22298https://curecurrent.com/trials/long-term-function-of-beta-cell-allografts-in-non-uremic-type-1-diabetic-patients-22299https://curecurrent.com/trials/bet-cell-therapy-in-diabetes-type-1-22300https://curecurrent.com/trials/study-to-assess-the-dietary-carbohydrate-content-of-indian-diabetic-population-22301https://curecurrent.com/trials/beta-cell-function-in-pre-type-1-diabetes-22302https://curecurrent.com/trials/efficacy-study-of-standard-ballroom-and-latin-dance-program-in-type-2-diabetes-and-obesity-22303https://curecurrent.com/trials/the-effect-of-epidural-steroid-injections-on-glycemic-control-in-diabetic-patients-according-to-the-doses-of-steroids-22304https://curecurrent.com/trials/effect-of-the-adjunctive-ivb-before-prp-22305https://curecurrent.com/trials/electrical-stimulation-and-expression-of-vegf-and-no-in-diabetic-foot-ulcer-22306https://curecurrent.com/trials/liraglutide-efficacy-on-glucocorticoid-induced-hyperglycemia-in-patients-high-risk-for-diabetes-22307https://curecurrent.com/trials/effect-of-bile-acids-on-glp-1-secretion-22308https://curecurrent.com/trials/effect-of-pomegranate-extract-intake-on-body-composition-and-blood-pressure-22309https://curecurrent.com/trials/the-addition-study-intensive-treatment-in-people-with-screen-detected-diabetes-in-primary-care-22310https://curecurrent.com/trials/effect-of-yellow-pea-protein-and-fibre-added-to-a-high-carb-meal-on-glycemic-response-and-food-intake-22311https://curecurrent.com/trials/effects-of-5-aminolevulinic-acid-on-glucose-metabolism-22312https://curecurrent.com/trials/the-effect-of-potato-fries-processing-on-food-intake-satiety-and-blood-glucose-22313https://curecurrent.com/trials/maraviroc-abacavir-study-effect-on-endothelial-recovery-22314https://curecurrent.com/trials/matrix-metalloproteinase-1-tissue-inhibitor-of-metalloproteinase-1-mmp-1-timp-1-ratio-and-diabetic-foot-ulcers-22315https://curecurrent.com/trials/the-food-intake-satiety-and-blood-glucose-after-ingestion-of-potato-chips-produced-from-three-potato-cultivars-22316https://curecurrent.com/trials/a-study-comparing-insulin-intensification-therapies-in-patients-with-type-2-diabetes-mellitus-22317https://curecurrent.com/trials/evaluate-safety-as-mono-or-combination-therapies-with-anti-diabetes-mellitus-drugs-in-japanese-subjects-with-type-2-diab-22318https://curecurrent.com/trials/trial-comparing-metabolic-effects-of-telmisartan-and-amlodipine-on-hypertensive-patients-with-obesity-and-diabetes-22319https://curecurrent.com/trials/glp-1-and-non-exercise-activity-thermogenesis-in-rhz-22320https://curecurrent.com/trials/beraprost-sodium-and-arterial-stiffness-in-patients-with-type-2-diabetic-nephropathy-22321https://curecurrent.com/trials/dietary-advanced-glycation-end-products-and-insulin-resistance-in-overweight-and-obese-humans-22322https://curecurrent.com/trials/improvement-of-sensibility-in-the-foot-in-diabetic-patients-induced-by-emla-application-to-the-lower-leg-22323https://curecurrent.com/trials/standardized-procedure-for-the-assessment-of-new-to-market-continuous-glucose-monitoring-systems-22324https://curecurrent.com/trials/a-bioequivalence-study-of-the-fixed-dose-combinations-of-saxagliptin-metformin-xr-relative-to-co-administration-22325https://curecurrent.com/trials/multicentric-evaluation-of-two-telematics-systems-in-type-2-diabetic-patients-in-failure-of-oral-treatment-and-having-to-22326https://curecurrent.com/trials/a-study-of-multiple-oral-doses-of-jnj-41443532-in-patients-with-type-2-diabetes-mellitus-22327https://curecurrent.com/trials/efficacy-of-continuous-subcutaneous-insulin-infusion-versus-basal-bolus-multiple-daily-injections-regimen-in-type-2-diab-22328https://curecurrent.com/trials/effect-of-allopurinol-treatment-on-insulin-resistance-22329https://curecurrent.com/trials/twentyfour-ambulatory-pulse-wave-velocity-and-central-augmentation-index-in-type-2-diabetes-22330https://curecurrent.com/trials/type-2-diabetes-mellitus-new-approaches-to-optimize-medical-care-in-general-practice-22331https://curecurrent.com/trials/intervention-to-promote-changes-of-healthy-lifestyle-physical-activity-and-nutrition-during-gestation-22332https://curecurrent.com/trials/the-effect-of-mashed-potato-composition-on-food-intake-satiety-and-blood-glucose-22333https://curecurrent.com/trials/a-trial-investigating-nn1218-in-subjects-with-type-1-diabetes-22334https://curecurrent.com/trials/the-effect-of-glp-1-on-the-inhibition-of-glucagon-secretion-22335https://curecurrent.com/trials/metabolic-phenotyping-of-individuals-born-following-assisted-reproduction-techniques-22336https://curecurrent.com/trials/marathon-runners-compared-to-sedentary-matched-control-subjects-22337https://curecurrent.com/trials/effects-of-a-mediterranean-style-diet-on-vascular-health-in-type-2-diabetes-22338https://curecurrent.com/trials/efficacy-of-small-subcutaneous-glucagon-dose-to-treat-hypoglycemia-in-adults-with-type-1-diabetes-22339https://curecurrent.com/trials/autologous-bone-marrow-mononuclear-cells-therapy-in-diabetic-lower-limb-ischemia-22340https://curecurrent.com/trials/a-randomized-cross-over-trial-of-the-postprandial-effects-of-three-different-diets-in-patients-with-type-2-diabetes-22341https://curecurrent.com/trials/gip-glp-1-and-glp-2-in-type-2-diabetic-hyperglucagonemia-22342https://curecurrent.com/trials/saxagliptin-compared-to-glimepiride-in-elderly-type-2-diabetes-patients-with-inadequate-glycemic-control-on-metformin-22343https://curecurrent.com/trials/trial-investigating-the-safety-of-nnc-0113-0987-in-healthy-male-subjects-22344https://curecurrent.com/trials/comparison-of-the-effect-of-nn5401-with-the-effect-of-nn1250-and-insulin-aspart-in-type-1-diabetics-22345https://curecurrent.com/trials/a-trial-investigating-the-effect-of-nn5401-in-subjects-with-type-2-diabetes-22346https://curecurrent.com/trials/a-trial-assessing-changes-in-blood-sugar-and-the-number-of-periods-where-supplementation-of-carbohydrate-is-needed-to-tr-22347https://curecurrent.com/trials/pharmacokinetic-pharmacodynamic-drug-drug-interaction-of-da-1229-and-metformin-after-oral-administration-in-healthy-male-22348https://curecurrent.com/trials/comparison-of-two-identical-nn1250-formulations-in-healthy-volunteers-22349https://curecurrent.com/trials/a-trial-investigating-the-effect-of-nn1250-in-japanese-subjects-with-type-2-diabetes-22350https://curecurrent.com/trials/self-management-using-smartphone-application-for-type2-dm-in-real-situation-smart-dm-22351https://curecurrent.com/trials/comparison-of-the-effect-of-nn5401-with-the-effect-of-nn1250-and-insulin-aspart-in-subjects-with-type-1-diabetes-22352https://curecurrent.com/trials/effect-of-arginine-on-microcirculation-in-patients-with-diabetes-22353https://curecurrent.com/trials/role-of-indicator-test-neuropad-in-detecting-diabetic-neuropathy-22354https://curecurrent.com/trials/effects-of-vitamin-d-supplementation-on-glucose-metabolism-in-women-with-former-gestational-diabetes-mellitus-22355https://curecurrent.com/trials/changes-in-glucose-metabolism-after-roux-en-y-gastric-bypass-22356https://curecurrent.com/trials/the-effect-of-high-dose-folic-acid-versus-placebo-on-the-rate-of-gestational-diabetes-or-gestational-hypertension-in-pre-22357https://curecurrent.com/trials/effects-of-exercise-therapy-on-ventricular-and-endothelial-function-in-patients-after-coronary-artery-bypass-surgery-22358https://curecurrent.com/trials/dmbss-a-randomized-trial-of-different-laparoscopic-gastric-bypass-surgery-in-patients-with-obesity-related-t2dm-22359https://curecurrent.com/trials/management-of-hyperglycemia-in-the-er-a-randomized-clinical-trial-of-a-subcutaneous-insulin-aspart-protocol-coupled-with-22360https://curecurrent.com/trials/effect-of-polyphenol-rich-dark-chocolate-on-insulin-sensitivity-in-normal-weight-and-overweight-adults-22361https://curecurrent.com/trials/mixed-meal-test-in-type-1-diabetes-optimization-of-artificial-pancreas-pilot-study-22362https://curecurrent.com/trials/efficacy-and-safety-study-of-shr117887-in-combination-with-metformin-in-patients-with-type-2-diabetes-22363https://curecurrent.com/trials/the-statins-on-glucose-homeostasis-in-subjects-with-impaired-fasting-glucose-22364https://curecurrent.com/trials/evaluation-of-exercise-benefits-to-promote-health-aging-among-chronically-ill-geriatrics-in-a-community-22365https://curecurrent.com/trials/impact-of-c242t-polymorphism-of-p22phox-in-diabetic-type1-nephropathy-22366https://curecurrent.com/trials/guidelines-for-post-exercise-dietary-intake-in-t1dm-22367https://curecurrent.com/trials/web-based-collaborative-care-for-patients-with-diabetes-and-depression-22368https://curecurrent.com/trials/off-loading-shoe-to-improve-healing-and-prevention-of-recurrence-of-neuropathic-diabetic-plantar-foot-ulcers-22369https://curecurrent.com/trials/vitamin-e-or-lipoic-acid-on-serum-oxyphytosterol-concentrations-22370https://curecurrent.com/trials/testosterone-therapy-of-men-with-type-2-diabetes-mellitus-t2dm-22371https://curecurrent.com/trials/1-year-trial-telmisartan-80-mg-versus-valsartan-160-mg-in-hypertensive-type-2-diabetic-patients-with-overt-nephropathy-22372https://curecurrent.com/trials/glucobay-m-observation-study-for-efficacy-and-safety-in-treatment-of-type-2-diabetes-patients-22373https://curecurrent.com/trials/cocoa-flavanols-and-painfree-walking-distance-22374https://curecurrent.com/trials/prospective-clinical-trials-on-skin-wound-healing-in-young-and-aged-individuals-22375https://curecurrent.com/trials/study-of-combination-therapy-with-syr-322-22376https://curecurrent.com/trials/genetics-of-type-1-diabetes-in-chinese-adolescents-and-youth-22377https://curecurrent.com/trials/evaluation-of-the-safety-and-efficacy-of-insulin-glargine-glulisine-or-insulin-regular-nph-insulin-isophane-insulin-use-22378https://curecurrent.com/trials/short-term-alpha-lipoic-acid-therapy-for-prevention-of-contrast-induced-acute-kidney-injury-and-endothelial-dysfunction-22379https://curecurrent.com/trials/trial-to-compare-the-effects-of-either-telmisartan-40-80-mg-po-once-daily-or-ramipril-5-10-mg-po-once-daily-on-renal-end-22380https://curecurrent.com/trials/a-trial-to-demonstrate-bioequivalence-between-two-insulin-degludec-liraglutide-formulations-b5-and-v2-in-healthy-subject-22381https://curecurrent.com/trials/new-onset-diabetes-and-left-ventricular-hypertrophy-in-renal-transplantation-22382https://curecurrent.com/trials/meal-timing-on-postprandial-glucose-insulin-and-glp-1-in-type-2-diabetes-22383https://curecurrent.com/trials/association-between-mortality-and-diabetes-in-elderly-koreans-the-south-west-seoul-sws-study-22384https://curecurrent.com/trials/glycaemic-load-and-pre-meal-insulin-doses-in-type-1-diabetes-patients-22385https://curecurrent.com/trials/pharmacist-intervention-for-glycemic-control-in-the-community-22386https://curecurrent.com/trials/a-phase-i-study-of-8-week-continuous-treatment-with-polyethylene-glycol-loxenatide-in-patients-with-type-2-diabetes-22387https://curecurrent.com/trials/reservoir-based-polymer-free-amphilimus-eluting-stent-versus-polymer-based-everolimus-eluting-stent-in-diabetic-patients-22388https://curecurrent.com/trials/the-effect-of-supplementation-with-two-different-doses-of-vitamin-d-on-bone-mineral-density-vitamin-d-levels-and-hand-gr-22389https://curecurrent.com/trials/telephone-use-for-care-of-persons-with-diabetes-mellitus-22390https://curecurrent.com/trials/innovation-study-telmisartan-micardis-in-incipient-diabetic-nephropathy-22391https://curecurrent.com/trials/detail-study-diabetes-exposed-to-telmisartan-and-enalapril-22392https://curecurrent.com/trials/prevention-and-treatment-of-diabetes-complications-with-gastric-surgery-or-intensive-medicines-22393https://curecurrent.com/trials/trial-to-investigate-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-single-oral-doses-of-bi135585-xx-admin-22394https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-zyd1-following-subcutaneous-administration-22395https://curecurrent.com/trials/3d-camera-telemedical-foot-ulcer-treatment-22396https://curecurrent.com/trials/safety-and-tolerability-of-oshadi-icp-in-patients-with-type-1-diabetes-mellitus-phase-ib-clinical-study-22397https://curecurrent.com/trials/malignancy-meta-analysis-for-brl49653-22398https://curecurrent.com/trials/the-effect-of-maximum-body-weight-in-lifetime-on-the-development-of-type-2-diabetes-22399https://curecurrent.com/trials/sitagliptin-versus-insulin-dose-increase-in-type-2-diabetes-on-insulin-treatment-22400https://curecurrent.com/trials/efficacy-and-safety-study-of-sp2086-in-combination-with-metformin-in-patients-with-type-2-diabetes-22401https://curecurrent.com/trials/a-phase-iii-study-of-sp2086-in-combination-with-metformin-in-patients-with-type-2-diabetes-22402https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-sp2086-to-treat-type-2-diabetes-22403https://curecurrent.com/trials/the-effect-of-roux-en-y-gastric-bypass-on-insulin-sensitivity-in-type-2-diabetes-22404https://curecurrent.com/trials/metabolic-effects-of-lactobacillus-reuteri-dsm-17938-in-type-2-diabetes-22405https://curecurrent.com/trials/efficacy-and-safety-of-sp2086-as-monotherapy-in-patients-with-type-2-diabetes-22406https://curecurrent.com/trials/food-effect-bioavailability-study-of-fdc-gemigliptin-metformin-hcl-sustained-release-50-1000mg-25-500mg-x-2tablets-22407https://curecurrent.com/trials/exercise-and-technology-to-reduce-risk-in-a-rural-population-with-metabolic-syndrome-22408https://curecurrent.com/trials/effects-of-exenatide-on-obesity-and-or-diabetes-mellitus-due-to-hypothalamic-damage-22409https://curecurrent.com/trials/effect-of-angiotensin-receptor-blockade-on-insulin-resistance-and-adipose-tissue-cytokines-in-type-2-diabetes-22410https://curecurrent.com/trials/a-phase-i-study-of-polyethylene-glycol-loxenatide-in-patients-with-type-2-diabetes-22411https://curecurrent.com/trials/a-pk-pd-study-of-polyethylene-glycol-loxenatide-in-patients-with-type-2-diabetes-22412https://curecurrent.com/trials/vildagliptin-compared-to-gliclazide-as-dual-therapy-with-metformin-in-muslim-patients-with-type-2-diabetes-fasting-durin-22413https://curecurrent.com/trials/effect-of-rubus-occidentalis-extract-on-plasma-glucose-levels-in-subject-with-prediabetes-22414https://curecurrent.com/trials/illness-crisis-adapting-in-early-or-middle-phase-of-patient-with-chronic-disease-study-of-meta-cognition-model-22415https://curecurrent.com/trials/metformin-and-pioglitazone-effects-on-ykl-40-concentrations-in-type-2-diabetes-patients-22416https://curecurrent.com/trials/obstructive-sleep-apnea-and-diabetes-mellitus-22417https://curecurrent.com/trials/effect-of-magnesium-administration-in-subjects-with-family-history-of-diabetes-or-metabolic-syndrome-22418https://curecurrent.com/trials/safety-and-efficacy-of-intravitreal-ranibizumab-as-a-preoperative-adjunct-treatment-before-vitrectomy-surgery-in-prolife-22419https://curecurrent.com/trials/increased-activity-of-a-renal-salt-transporter-enac-in-diabetic-kidney-disease-22420https://curecurrent.com/trials/does-vildagliptin-affect-portal-vein-pressure-in-patients-with-type-2-diabetes-mellitus-a-cross-sectional-study-22421https://curecurrent.com/trials/trial-to-evaluate-the-efficacy-and-safety-of-dapagliflozin-in-japanese-type-2-diabetes-mellitus-patients-22422https://curecurrent.com/trials/efficacy-and-safety-of-dapagliflozin-in-combination-with-glimepiride-a-sulphonylurea-in-type-2-diabetes-patients-22423https://curecurrent.com/trials/diagnostic-utility-of-copeptin-in-addition-to-high-sensitivity-cardiac-troponin-for-the-early-diagnosis-of-nste-acs-22424https://curecurrent.com/trials/evaluation-of-the-effect-of-dapagliflozin-in-combination-with-metformin-on-body-weight-in-subjects-with-type-2-diabetes-22425https://curecurrent.com/trials/study-on-the-comparison-between-standard-noodles-and-traditional-carbohydrates-in-the-diagnosis-of-diabetes-mellitus-22426https://curecurrent.com/trials/liraglutide-treatment-to-patients-with-severe-renal-insufficiency-22427https://curecurrent.com/trials/safety-and-efficacy-study-of-onglyza-saxagliptin-under-conditions-of-actual-use-22428https://curecurrent.com/trials/short-term-intensive-insulin-therapy-induction-of-long-term-glycemic-control-22429https://curecurrent.com/trials/the-acute-effects-of-low-dose-tnf-on-glucose-metabolism-and-cell-function-in-humans-22430https://curecurrent.com/trials/insole-optimisation-for-ulcer-prevention-a-feasibility-trial-22431https://curecurrent.com/trials/study-to-evaluate-beta-cell-function-and-glycemic-outcome-by-intensive-insulin-therapy-22432https://curecurrent.com/trials/the-periodontal-disease-and-diabetes-mellitus-interrelationship-among-adult-malaysians-22433https://curecurrent.com/trials/efficacy-and-safety-of-oral-acarbose-treatment-in-patients-with-type-2-diabetes-mellitus-22434https://curecurrent.com/trials/closing-the-loop-in-youth-with-type-1-diabetes-in-the-home-setting-22435https://curecurrent.com/trials/rule-based-closed-loop-system-for-type-1-diabetes-control-22436https://curecurrent.com/trials/effectiveness-study-of-hydrotherapy-against-pain-and-other-symptoms-in-diabetes-induced-lead-22437https://curecurrent.com/trials/the-role-of-nitazoxanide-interferon-alfa-and-ribavirin-in-treatment-of-hepatitis-c-infected-type-2-diabetic-patients-22438https://curecurrent.com/trials/hyperbaric-oxygen-treatment-ameliorates-insulin-resistance-22439https://curecurrent.com/trials/prospective-cohort-study-of-the-body-constitution-among-type-ii-diabetes-mellitus-patients-22440https://curecurrent.com/trials/vitamin-c-supplementation-plus-hypoglycemic-agents-versus-hypoglycemic-agents-alone-in-type-2-diabetes-mellitus-22441https://curecurrent.com/trials/ready-to-act-health-education-in-people-with-hyperglycaemia-22442https://curecurrent.com/trials/early-feasibility-study-2-of-outpatient-control-to-range-testing-system-efficacy-france-22443https://curecurrent.com/trials/study-to-evaluate-safety-and-tolerability-of-pegaptanib-sodium-in-patients-with-diabetic-macular-edema-22444https://curecurrent.com/trials/effect-of-atorvastatin-on-vascular-inflammation-in-type-2-diabetes-22445https://curecurrent.com/trials/japan-prevention-trial-of-diabetes-by-pitavastatin-in-patients-with-impaired-glucose-tolerance-j-predict-22446https://curecurrent.com/trials/the-effects-of-glp-1-in-maturity-onset-diabetes-of-the-young-mody-22447https://curecurrent.com/trials/influence-of-glitazones-on-the-vasodilatory-effect-of-high-density-lipoprotein-hdl-lipoproteins-22448https://curecurrent.com/trials/bone-marrow-progenitor-cell-mobilization-in-diabetes-22449https://curecurrent.com/trials/the-smart-oracle-study-22450https://curecurrent.com/trials/study-to-assess-the-effect-of-24-weeks-of-treatment-with-vildagliptin-in-patients-with-type-2-diabetes-22451https://curecurrent.com/trials/comparison-of-pk-after-administration-of-hcp1201-and-co-administration-of-metformin-sr-750mg-and-rosuvastatin-20mg-22452https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-50mg-bid-as-an-add-on-therapy-to-insulin-with-or-without-metformin-in-patients-with-22453https://curecurrent.com/trials/hypoglycemic-effects-of-fermented-red-ginseng-in-subject-with-impaired-fasting-glucose-or-type-2-diabetes-22454https://curecurrent.com/trials/a-3-fold-crossover-bioequivalence-study-between-glucobay-orally-disintegrating-tablet-odt-and-glucobay-standard-tablet-22455https://curecurrent.com/trials/evaluating-a-pharmacokinetic-drug-interaction-between-metformin-hydrochloride-and-rosuvastatin-calcium-22456https://curecurrent.com/trials/body-weight-effects-on-glucophage-s-efficacy-in-chinese-diagnosed-t2dm-patients-22457https://curecurrent.com/trials/polymorphids-an-mrna-expression-in-obese-genes-22458https://curecurrent.com/trials/endothelial-function-in-hispanic-children-adolescents-at-risk-for-type-2-diabetes-22459https://curecurrent.com/trials/effect-of-different-interventions-on-glycemic-control-and-cell-function-in-newly-diagnosed-type-2-diabetic-patients-22460https://curecurrent.com/trials/repeated-dose-study-with-a-new-insulin-glargine-formulation-and-lantus-on-24-hour-glucose-profile-in-japanese-patients-w-22461https://curecurrent.com/trials/study-to-evaluate-safety-and-pk-pd-of-da-3091-in-healthy-male-subjects-22462https://curecurrent.com/trials/a-study-to-evaluate-the-safety-of-da-3030-and-to-explore-the-efficacy-for-diabetic-neuropathic-pain-22463https://curecurrent.com/trials/effects-of-5-day-statin-withdrawal-on-endothelial-progenitor-cells-and-inflammatory-markers-in-type-2-diabetic-patients-22464https://curecurrent.com/trials/euglycemic-clamp-study-comparing-two-new-insulin-glargine-formulations-in-subjects-with-type-1-diabetes-mellitus-22465https://curecurrent.com/trials/single-dose-2-way-crossover-open-study-to-evaluate-the-food-effect-on-the-pk-of-hcp1201-in-healthy-volunteers-22466https://curecurrent.com/trials/a-study-to-compare-safety-and-efficacy-of-tramadol-hydrochloride-acetaminophen-with-gabapentin-in-participants-with-diab-22467https://curecurrent.com/trials/diabetic-foot-and-vascular-progenitor-cells-22468https://curecurrent.com/trials/very-low-density-lipoprotein-triglyceride-vldl-tg-metabolism-during-acute-hyperglycemia-22469https://curecurrent.com/trials/metformin-as-adjuvant-to-insulin-therapy-in-insulin-resistant-diabetes-mellitus-with-pregnancy-22470https://curecurrent.com/trials/a-clinical-trial-to-study-the-efficacy-safety-tolerability-and-pharmacokinetics-of-p2202-in-patients-of-type-2-diabetes-22471https://curecurrent.com/trials/liraglutide-and-insulin-therapy-in-patients-with-type-2-diabetes-22472https://curecurrent.com/trials/a-trial-investigating-the-safety-tolerability-and-distribution-and-activity-in-the-body-of-nnc0148-0000-0287-injected-un-22473https://curecurrent.com/trials/the-effect-of-korean-red-ginseng-supplementation-on-glucose-control-22474https://curecurrent.com/trials/additional-glp-1-analogue-on-csii-treatment-for-poorly-controlled-type-2-diabetic-patients-22475https://curecurrent.com/trials/effect-of-omega-3-fatty-acids-on-insulin-sensitivity-in-chinese-gestational-diabetic-patients-22476https://curecurrent.com/trials/pharmacokinetic-and-pharmacodynamic-properties-of-biod-123-and-biod-125-compared-to-humalog-in-subjects-with-type-1-diab-22477https://curecurrent.com/trials/management-of-albuminuria-in-hypertensive-diabetics-22478https://curecurrent.com/trials/clinical-trial-on-diabetes-expert-patients-programme-22479https://curecurrent.com/trials/cord-blood-infusion-for-type-1-diabetes-mellitus-t1dm-22480https://curecurrent.com/trials/effects-of-legume-intake-on-cardiovascular-risk-factors-among-adults-at-risk-for-diabetes-22481https://curecurrent.com/trials/a-safety-and-efficacy-study-for-tapentadol-cg5503-extended-release-for-patients-with-painful-diabetic-peripheral-neuropa-22482https://curecurrent.com/trials/a-comparison-chocolate-with-and-without-high-cocoa-solids-in-patients-with-type-2-diabetes-in-a-randomised-clinical-tria-22483https://curecurrent.com/trials/an-evaluation-of-glycemic-control-effects-of-mono-therapy-ckd-501-in-patients-with-type-2-diabetes-mellitus-22484https://curecurrent.com/trials/a-study-to-evaluate-safety-and-pharmacokinetics-pharmacodynamics-of-sustained-release-sr-exenatide-22485https://curecurrent.com/trials/clinical-verification-of-peptide-biomarkers-for-type-2-diabetes-mellitus-22486https://curecurrent.com/trials/periodontal-treatment-and-glycemic-control-22487https://curecurrent.com/trials/a-randomized-trial-to-assess-the-efficacy-and-safety-of-go2ka1-chitosan-oligosaccharide-on-blood-glucose-control-22488https://curecurrent.com/trials/mdrs-for-prevention-of-nocturnal-hypoglycemia-22489https://curecurrent.com/trials/effect-of-acute-exercise-on-endothelial-function-in-patients-with-type-1-diabetes-22490https://curecurrent.com/trials/reduction-of-foveal-sensitivity-in-eyes-with-diabetic-macular-edema-22491https://curecurrent.com/trials/teamcare-pcn-collaborative-care-for-diabetes-and-depression-22492https://curecurrent.com/trials/healthy-eating-active-living-for-diabetes-in-primary-care-networks-22493https://curecurrent.com/trials/long-term-treatment-effect-of-diapep277-in-type-1-diabetes-22494https://curecurrent.com/trials/dietary-effects-on-circulating-lipoprotein-associated-phospholipase-a2-lp-pla2-activity-and-enzyme-activity-in-periphera-22495https://curecurrent.com/trials/triple-therapy-in-type-2-diabetic-patients-22496https://curecurrent.com/trials/the-effects-of-regular-home-use-vs-diabetic-team-supported-use-of-the-medtronic-carelink-therapy-management-system-22497https://curecurrent.com/trials/mk-0431-ono-5435-phase-iii-clinical-trial-rapid-acting-insulin-secretagogue-add-on-study-in-patients-with-type-2-diabete-22498https://curecurrent.com/trials/diabetes-peripheral-neuropathy-and-small-fibre-nerve-damage-a-comparative-study-22499https://curecurrent.com/trials/the-effect-of-intensive-multifactorial-therapy-on-endothelial-function-in-newly-diagnosed-type-2-diabetes-22500https://curecurrent.com/trials/evaluation-of-the-effectiveness-and-safety-of-physician-versus-patient-led-of-insulin-glargine-initiation-and-titration-22501https://curecurrent.com/trials/comparison-of-insulin-glargine-insulin-glulisine-regimen-to-insulin-aspart-insulin-aspart-protamine-30-70-in-type-2-diab-22502https://curecurrent.com/trials/use-of-the-freestyle-navigator-continuous-glucose-monitoring-system-to-enhance-education-and-glycaemic-control-22503https://curecurrent.com/trials/a-long-term-trial-to-compare-the-effects-of-liraglutide-and-sulphonylurea-glimepiride-both-in-combination-with-metformin-22504https://curecurrent.com/trials/treatment-by-insulin-continuous-infusion-in-type-2-diabetes-22505https://curecurrent.com/trials/biphasic-insulin-aspart-versus-nph-plus-regular-human-insulin-in-type-2-diabetic-patients-22506https://curecurrent.com/trials/metformin-therapy-in-type-1-diabetes-mellitus-22507https://curecurrent.com/trials/care-china-diabetes-22508https://curecurrent.com/trials/the-effects-of-short-term-exenatide-therapy-in-newly-diagnosed-type-2-diabetic-patients-22509https://curecurrent.com/trials/influence-of-catheter-based-renal-denervation-in-diseases-with-increased-sympathetic-activity-22510https://curecurrent.com/trials/diabetes-treatment-with-glucobay-in-combination-with-sulfonylurea-22511https://curecurrent.com/trials/glucose-variability-in-pregnancy-complicated-by-diabetes-22512https://curecurrent.com/trials/effect-of-dietary-fiber-on-glucose-lipids-in-non-insulin-dependent-diabetes-mellitus-niddm-22513https://curecurrent.com/trials/glucofriend-evaluation-the-effectiveness-of-glucobay-when-combined-with-a-basal-insulin-22514https://curecurrent.com/trials/impact-of-sleep-education-program-on-glycemic-control-in-hong-kong-chinese-type-2-diabetic-patients-22515https://curecurrent.com/trials/apad2-effects-of-rehabilitation-programme-in-adapted-physical-activity-apa-among-type-2-diabetics-22516https://curecurrent.com/trials/effects-of-dietary-polyphenols-and-3-fatty-acids-on-cardiovascular-risk-factors-in-high-risk-subjects-22517https://curecurrent.com/trials/ex-vivo-lps-stimulation-in-healthy-and-compromised-subjects-22518https://curecurrent.com/trials/autologous-transplantation-of-mesenchymal-stem-cells-for-treatment-of-patients-with-onset-of-type-1-diabetes-22519https://curecurrent.com/trials/effect-of-modifying-anti-platelet-treatment-to-ticagrelor-in-patients-with-diabetes-and-low-response-to-clopidogrel-22520https://curecurrent.com/trials/living-successfully-with-chronic-eye-diseases-22521https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ev-077-in-type-2-diabetic-subjects-22522https://curecurrent.com/trials/a-3-fold-crossover-bioequivalence-study-between-glucobay-odt-orally-disintegrating-tablet-100-mg-and-glucobay-standard-t-22523https://curecurrent.com/trials/immunogenicity-safety-and-tolerability-of-an-mf59-adjuvanted-versus-non-adjuvanted-influenza-vaccines-in-patients-with-c-22524https://curecurrent.com/trials/vitamin-d-and-omega-3-inhibit-metabolic-syndrome-22525https://curecurrent.com/trials/the-effect-of-vitamin-d-on-the-serum-thioredoxin-tbp-2-thioredoxin-reductase-gene-expression-of-tbp-2-in-patients-with-t-22526https://curecurrent.com/trials/serum-and-intraocular-levels-of-erythropoietin-and-vegf-in-type-2-diabetes-patients-with-proliferative-retinopathy-22527https://curecurrent.com/trials/proteomics-study-of-gastric-bypass-surgery-to-treat-type-2-diabetes-mellitus-22528https://curecurrent.com/trials/serum-1-25-dihydroxyvitamin-d-levels-in-type-2-diabetes-mellitus-patients-with-different-levels-of-albuminuria-22529https://curecurrent.com/trials/effect-of-the-biomarker-copeptin-in-managing-patients-with-suspected-acute-coronary-syndrome-acs-22530https://curecurrent.com/trials/ulcer-monitoring-in-diabetes-mellitus-22531https://curecurrent.com/trials/prospective-observational-study-assessing-treatment-and-outcomes-of-patients-with-prediabetes-22532https://curecurrent.com/trials/optimizing-audit-and-feedback-for-primary-care-22533https://curecurrent.com/trials/effects-of-benfotiamine-on-intraepidermal-nerve-fiber-density-ienfd-22534https://curecurrent.com/trials/effects-of-high-voltage-electrical-stimulation-shortwave-diathermy-and-kinesiotherapy-on-arterial-blood-flow-in-the-lowe-22535https://curecurrent.com/trials/a-trial-to-study-the-effect-of-vitamin-d-supplementation-on-glucose-and-insulin-metabolism-in-centrally-obese-men-22536https://curecurrent.com/trials/efficacy-safety-tolerability-and-pharmacokinetics-of-concomitant-administration-of-tramadol-with-duloxetine-or-pregabali-22537https://curecurrent.com/trials/better-acceptance-of-single-injection-apidra-added-to-once-daily-lantus-versus-twice-daily-premixed-insulin-in-real-life-22538https://curecurrent.com/trials/efficacy-and-safety-of-kw21052-compared-to-lyrica-in-the-diabetic-patients-with-neuropathic-pain-22539https://curecurrent.com/trials/study-on-periodontal-treatment-in-diabetic-patients-22540https://curecurrent.com/trials/efficacy-and-safety-of-add-on-therapy-with-dlbs3233-in-patients-with-type-2-diabetes-mellitus-22541https://curecurrent.com/trials/efficacy-of-alogliptin-and-with-pioglitazone-in-patients-with-type-2-diabetes-22542https://curecurrent.com/trials/analisys-of-neuromuscular-response-postural-balance-and-quality-of-life-of-diabetics-type-2-after-sensory-motor-training-22543https://curecurrent.com/trials/effect-of-ginseng-on-glycemic-control-22544https://curecurrent.com/trials/effects-of-berries-and-berry-fractions-on-metabolic-diseases-22545https://curecurrent.com/trials/a-study-of-improved-efficacy-safety-and-compliance-to-administer-insulin-in-pen-vs-vial-and-syringe-22546https://curecurrent.com/trials/the-effect-of-metformin-in-overweight-patients-with-dysregulated-type-1-diabetes-mellitus-22547https://curecurrent.com/trials/metformin-treatment-in-gestational-diabetes-and-noninsulin-dependent-diabetes-in-pregnancy-in-a-developing-country-22548https://curecurrent.com/trials/safety-and-efficacy-of-sitagliptin-added-to-insulin-therapy-for-type-2-diabetes-22549https://curecurrent.com/trials/study-of-single-ascending-doses-of-pbl-1427-in-healthy-volunteers-22550https://curecurrent.com/trials/the-effect-of-vitamin-d-supplementation-in-type-2-diabetes-22551https://curecurrent.com/trials/a-pharmacokinetic-study-to-compare-co-administration-of-repaglinide-and-metformin-hcl-to-administration-of-combination-p-22552https://curecurrent.com/trials/thyroid-study-type-2-diabetes-mellitus-t2dm-22553https://curecurrent.com/trials/cross-over-study-on-effect-of-lipid-lowering-by-acipimox-on-cardiac-and-skeletal-muscle-mitochondrial-function-22554https://curecurrent.com/trials/safety-and-efficacy-of-spirinolactone-plus-hydroflumethiazide-in-the-treatment-of-filipino-patients-with-hypertension-22555https://curecurrent.com/trials/multicentre-randomized-controlled-trial-of-qideng-mingmu-capsule-in-the-treatment-of-diabetic-retinopathy-22556https://curecurrent.com/trials/effects-of-vitamin-b1-in-type-1-diabetic-patients-22557https://curecurrent.com/trials/a-pilot-study-to-assess-the-safety-pk-and-pd-of-insulin-injected-via-micronjet-or-conventional-needle-22558https://curecurrent.com/trials/hyperbaric-oxygen-therapy-hbot-for-chronic-diabetic-lower-limb-ulcers-22559https://curecurrent.com/trials/a-study-of-the-effect-of-a-chronic-disease-management-system-on-diabetes-care-within-multidisciplinary-primary-care-prac-22560https://curecurrent.com/trials/effectiveness-of-two-interventions-in-patients-with-low-educational-level-with-diabetes-to-reduce-inequalities-in-self-c-22561https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-efficacy-and-safety-of-cilostazol-and-probucol-in-combination-on-patients-with-diabetic-22562https://curecurrent.com/trials/cardiovascular-effects-of-chronic-sildenafil-in-men-with-type-2-diabetes-22563https://curecurrent.com/trials/continuous-subcutaneous-insulin-infusion-strategy-versus-multiple-daily-insulin-injections-strategy-22564https://curecurrent.com/trials/fetal-heart-interventricular-septum-in-fetuses-of-diabetic-mothers-22565https://curecurrent.com/trials/trientine-hydrochloride-for-the-prevention-of-macular-edema-associated-with-pan-retinal-photocoagulation-for-severe-non-22566https://curecurrent.com/trials/comparison-of-valsartan-with-amlodipine-in-hypertensive-patients-with-glucose-intolerance-22567https://curecurrent.com/trials/post-authorisation-safety-study-of-samsca-tolvaptan-used-in-routine-medical-practice-22568https://curecurrent.com/trials/the-effect-of-green-tea-extract-on-type-2-diabetes-with-hyperlipidemia-22569https://curecurrent.com/trials/metformin-dipyridamole-interaction-trial-22570https://curecurrent.com/trials/hypoglycemia-at-initiation-of-pump-therapy-in-children-with-type-1-diabetes-22571https://curecurrent.com/trials/prevalence-of-hba1c-in-women-with-pcos-22572https://curecurrent.com/trials/the-aging-endocrine-pancreas-characterization-of-the-entero-insular-axis-physiology-in-the-elderly-22573https://curecurrent.com/trials/a-study-of-two-methods-for-determining-the-renal-threshold-for-glucose-in-patients-with-type-2-diabetes-mellitus-22574https://curecurrent.com/trials/validation-of-algorithms-for-basal-insulin-rate-reductions-in-type-1-diabetic-patients-practising-physical-activity-22575https://curecurrent.com/trials/tactile-massage-in-type-2-diabetes-22576https://curecurrent.com/trials/study-to-assess-the-efficacy-and-safety-of-sk3530-on-erectile-dysfunction-in-patients-with-diabetes-mellitus-22577https://curecurrent.com/trials/avandia-amaryl-or-avandamet-compared-with-metformin-avalanche-study-22578https://curecurrent.com/trials/electrolyte-and-fluid-disturbances-in-subarachnoid-hemorrhage-and-traumatic-brain-injury-22579https://curecurrent.com/trials/cost-effectiveness-of-glargine-insulin-versus-nph-insulin-22580https://curecurrent.com/trials/performance-study-to-test-the-glucomen-day-system-using-intravascular-and-subcutaneous-microdialysis-in-subjects-with-ty-22581https://curecurrent.com/trials/protein-profile-of-immunoregulatory-factors-in-diabetic-cataract-22582https://curecurrent.com/trials/non-enhanced-magnetic-resonance-angiography-of-diabetic-ischemic-lower-limbs-22583https://curecurrent.com/trials/management-of-type-2-diabetic-patients-treated-with-insulin-during-the-ramadan-22584https://curecurrent.com/trials/capsaicin-nanoparticle-in-patient-with-painful-diabetic-neuropathy-22585https://curecurrent.com/trials/pilot-study-of-glycemic-control-in-diabetic-hemodialyzed-patients-22586https://curecurrent.com/trials/insulin-lispro-6-days-versus-insulin-aspart-6-days-in-pump-use-22587https://curecurrent.com/trials/rosuvastatin-prevent-contrast-induced-acute-kidney-injury-in-patients-with-diabetes-22588https://curecurrent.com/trials/performance-of-a-tablet-based-workflow-and-decision-support-system-with-incorporated-software-algorithm-used-for-glycaem-22589https://curecurrent.com/trials/melatonin-for-prevention-of-metabolic-side-effects-of-olanzapine-22590https://curecurrent.com/trials/metformin-and-gestational-diabetes-in-high-risk-patients-a-rcts-22591https://curecurrent.com/trials/vildagliptin-in-new-onset-diabetes-after-transplantation-22592https://curecurrent.com/trials/exercise-training-in-patients-with-coronary-heart-disease-and-type-2-diabetes-22593https://curecurrent.com/trials/insulins-glargine-and-glulisine-strategy-versus-premixed-insulin-strategy-a-comparative-study-22594https://curecurrent.com/trials/nighttime-dosing-of-antihypertensive-drugs-in-type-2-diabetes-22595https://curecurrent.com/trials/evaluation-of-the-effects-of-heating-or-massaging-or-vibrating-at-the-vicinity-of-the-insulin-delivery-site-22596https://curecurrent.com/trials/use-of-intravitreal-ranibizumab-in-the-treatment-of-vitreous-hemorrhage-22597https://curecurrent.com/trials/closing-the-loop-in-young-children-with-type-1-diabetes-22598https://curecurrent.com/trials/gip-effects-at-insulin-induced-hypoglycemia-in-patients-with-type-2-diabetes-22599https://curecurrent.com/trials/a-comparison-between-pupillometry-heart-rate-variability-and-metaiodobenzylguanidine-scintigraphy-for-the-diagnosis-of-e-22600https://curecurrent.com/trials/a-study-of-the-effects-of-exercise-intensity-on-insulin-sensitivity-in-overweight-youth-22601https://curecurrent.com/trials/study-comparing-efficacy-and-safety-of-amaryl-m-and-metformin-uptitraion-to-type-2-dm-22602https://curecurrent.com/trials/efficacy-safety-study-of-amaryl-m-1-500-mg-twice-daily-versus-amaryl-4-mg-both-in-combination-with-lantus-in-type-2-diab-22603https://curecurrent.com/trials/telephone-counselling-to-promote-physical-activity-in-diabetes-mellitus-people-22604https://curecurrent.com/trials/open-label-study-of-tak-875-22605https://curecurrent.com/trials/autologous-bone-marrow-stem-cell-transfer-in-patients-with-chronical-critical-limb-ischemia-and-diabetic-foot-22606https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-in-participants-with-type-2-diabetes-22607https://curecurrent.com/trials/study-assessing-safety-and-efficacy-of-b-cure-laser-treating-diabetic-chronic-wounds-22608https://curecurrent.com/trials/intensive-life-style-intervention-in-type-2-diabetes-patients-22609https://curecurrent.com/trials/two-pieces-of-fruit-to-type-2-diabetics-22610https://curecurrent.com/trials/treatment-use-of-generex-oral-lyn-in-patients-with-diabetes-22611https://curecurrent.com/trials/genetic-markers-of-coronary-heart-disease-in-type-2-diabetes-22612https://curecurrent.com/trials/pharmacokinetic-and-injection-site-toleration-of-biod-238-and-biod-250-compared-to-humalog-in-subjects-with-type-1-diabe-22613https://curecurrent.com/trials/safety-and-efficacy-study-of-vitrase-for-clearance-of-severe-vitreous-hemorrhage-22614https://curecurrent.com/trials/impairment-in-glucose-homeostasis-among-obese-adolescents-in-high-risk-diabetes-prone-population-jisr-az-zarqa-village-22615https://curecurrent.com/trials/sex-specific-association-with-kidney-disease-22616https://curecurrent.com/trials/metformin-and-longevity-genes-in-prediabetes-22617https://curecurrent.com/trials/testing-the-effect-of-the-insupad-device-in-daily-life-conditions-22618https://curecurrent.com/trials/the-effect-of-a-low-glycemic-index-diet-on-blood-sugar-control-in-pregnant-women-at-risk-for-gestational-diabetes-22619https://curecurrent.com/trials/pharmacology-of-insulin-injected-with-jet-injection-in-diabetes-22620https://curecurrent.com/trials/the-effect-of-continuous-sipping-of-a-glucose-solution-on-markers-of-oxidation-in-men-and-women-22621https://curecurrent.com/trials/severe-insulin-resistance-in-patients-with-type-2-diabetes-22622https://curecurrent.com/trials/progression-from-impaired-fasting-glucose-to-type-2-diabetes-mellitus-among-subjects-with-and-without-hypertension-in-pr-22623https://curecurrent.com/trials/new-frontiers-on-bariatric-surgical-procedures-classical-bypass-for-type-2-diabetic-patients-with-obesity-grade-i-22624https://curecurrent.com/trials/cardiopulmonary-fitness-lung-function-muscular-oxygen-saturation-and-quality-of-life-in-t1dm-22625https://curecurrent.com/trials/prevalence-of-metabolic-syndrome-in-atahualpa-22626https://curecurrent.com/trials/restoration-of-beta-cell-function-and-cardiovascular-parameters-in-relation-to-adipoinsular-and-enteroinsular-axes-after-22627https://curecurrent.com/trials/effects-of-acute-intake-of-caffeinated-beverages-in-type-1-diabetes-22628https://curecurrent.com/trials/glucose-metabolism-effects-of-vitamin-d-supplementation-in-prediabetes-22629https://curecurrent.com/trials/intravitreal-bevacizumab-and-triamcinolone-associated-to-laser-photocoagulation-for-diabetic-macular-edema-ibeta-22630https://curecurrent.com/trials/effects-of-n-3-polyunsaturated-fatty-acids-on-chylomicron-secretion-and-expression-of-genes-that-regulate-intestinal-lip-22631https://curecurrent.com/trials/effect-of-diacylglycerol-oil-on-risk-factors-of-type-2-diabetes-and-complicating-disease-and-mechanism-22632https://curecurrent.com/trials/effects-of-acarbose-on-endothelial-function-after-a-mixed-meal-in-newly-diagnosed-type-2-diabetes-22633https://curecurrent.com/trials/the-effect-of-dbcare-a-food-supplement-on-diabetes-control-22634https://curecurrent.com/trials/resistance-exercise-in-already-active-diabetic-individuals-readi-trial-22635https://curecurrent.com/trials/assessment-of-efficacy-and-safety-of-insuman-comb-25-versus-novolin-30r-twice-daily-over-24-weeks-in-type-2-diabetes-pat-22636https://curecurrent.com/trials/corticosteroids-and-hemoglobin-a1c-levels-in-diabetic-patients-with-copd-exacerbation-22637https://curecurrent.com/trials/acetyl-l-carnitine-in-type-2-diabetes-22638https://curecurrent.com/trials/best-timing-of-insulin-bolus-before-meals-of-different-contents-22639https://curecurrent.com/trials/study-evaluating-eaa-090-in-adult-outpatients-with-neuropathic-pain-associated-with-diabetic-neuropathy-22640https://curecurrent.com/trials/management-of-dyslipidemia-in-adult-type-2-diabetes-patients-in-india-22641https://curecurrent.com/trials/preventing-renal-functional-abnormalities-with-calorie-restriction-in-subjects-with-abdominal-obesity-and-type-2-diabete-22642https://curecurrent.com/trials/insulin-regimens-and-vascular-functions-22643https://curecurrent.com/trials/predictors-of-future-type-2-diabetes-mellitus-in-circassians-minority-in-israel-22644https://curecurrent.com/trials/a-comprehensive-longitudinal-cohort-study-in-type-2-diabetes-with-high-risk-of-cardiovascular-diseases-in-china-22645https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-cj-30001-and-cj-30002-in-type-2-diabetes-mellitus-patients-22646https://curecurrent.com/trials/cohort-study-in-type-2-diabetes-in-china-22647https://curecurrent.com/trials/use-of-information-technology-in-the-prevention-of-diabetes-22648https://curecurrent.com/trials/evaluation-of-effectiveness-of-treatment-paradigm-for-newly-diagnosed-type-2-diabetes-patients-in-china-22649https://curecurrent.com/trials/efficacy-and-safety-of-ckd-501-versus-pioglitazone-when-added-to-metformin-22650https://curecurrent.com/trials/nox-e36-first-in-human-fih-study-22651https://curecurrent.com/trials/a-drug-interaction-study-of-slm0807-and-hkb0701-in-healthy-subjects-22652https://curecurrent.com/trials/gestational-diabetes-the-prevention-22653https://curecurrent.com/trials/effect-of-liraglutide-combined-with-short-term-csii-on-long-term-glycemic-remission-and-cell-function-22654https://curecurrent.com/trials/nox-e36-multiple-ascending-dose-study-in-healthy-volunteers-and-patients-with-type-2-diabetes-mellitus-22655https://curecurrent.com/trials/vildagliptin-versus-sitagliptin-differences-in-fasting-plasma-glucose-lowering-efficacy-22656https://curecurrent.com/trials/vasopressin-versus-norepinephrine-for-the-management-of-shock-after-cardiac-surgery-22657https://curecurrent.com/trials/regular-physical-exercise-extends-honeymoon-phase-in-type-1-diabetes-subjects-22658https://curecurrent.com/trials/study-evaluating-the-safety-and-efficacy-of-piperacillin-tazobactam-and-ampicillin-sulbactam-in-patients-with-diabetic-f-22659https://curecurrent.com/trials/diurnal-triglyceridemia-in-relation-to-alcohol-intake-22660https://curecurrent.com/trials/study-to-evaluate-the-effect-of-the-smart-care-diabetes-management-system-on-subjects-with-diabetes-22661https://curecurrent.com/trials/cognitive-function-and-electrocardiogram-ecg-during-hypoglycemia-and-blockade-of-the-renin-angiotensin-system-22662https://curecurrent.com/trials/comparison-of-glargine-and-oral-antidiabetic-drugs-oads-in-newly-diagnosed-type-2-diabetes-22663https://curecurrent.com/trials/feasibility-study-integrated-sensor-and-infusion-set-trial-iii-22664https://curecurrent.com/trials/feasibility-study-of-an-integrated-sensor-and-infusion-set-22665https://curecurrent.com/trials/a-trial-to-investigate-efficacy-and-usability-of-published-best-practice-to-control-glycaemia-22666https://curecurrent.com/trials/collection-of-performance-data-from-the-integrated-sensor-and-infusion-set-trial-4-22667https://curecurrent.com/trials/changes-in-mitochondrial-uncoupling-protein-2-ucp2-messenger-rna-mrna-in-type-2-diabetes-t2dm-patients-22668https://curecurrent.com/trials/interactive-studies-of-endstage-diabetic-dialysis-patients-22669https://curecurrent.com/trials/effects-of-gamma-aminobutyric-acid-on-the-progression-of-new-onset-juvenile-type-1-diabetes-22670https://curecurrent.com/trials/the-use-of-curexcelltm-in-a-community-setting-for-the-treatment-of-hard-to-heal-wounds-22671https://curecurrent.com/trials/registry-of-diabetes-patients-in-a-large-health-maintenance-organization-in-israel-22672https://curecurrent.com/trials/effectiveness-and-safety-of-treatment-of-insulin-glargine-in-type-2-diabetes-mellitus-following-glucagon-like-peptide-1-22673https://curecurrent.com/trials/diurnal-variation-of-exogenous-peptides-endogenous-insulin-jurgita-ii-22674https://curecurrent.com/trials/immunogenicity-study-of-wockhardt-s-insulin-lispro-lispro-mix-basal-bolus-regimen-in-type-1-diabetics-22675https://curecurrent.com/trials/a-study-to-assess-the-effect-of-topical-recombinant-human-vascular-endothelial-growth-factor-for-induction-of-healing-of-22676https://curecurrent.com/trials/diabetes-care-management-trial-of-telemetric-monitoring-22677https://curecurrent.com/trials/an-efficacy-and-safety-study-of-carisbamate-in-the-treatment-of-nerve-pain-in-diabetics-22678https://curecurrent.com/trials/a-study-in-painful-diabetic-neuropathy-22679https://curecurrent.com/trials/diet-insulin-sensitivity-and-the-brain-22680https://curecurrent.com/trials/anterior-and-posterior-segment-vascular-changes-following-laser-and-anti-vascular-endothelial-growth-factor-vegf-treatme-22681https://curecurrent.com/trials/diabetes-aerobic-and-resistance-exercise-dare-study-22682https://curecurrent.com/trials/efficacy-of-behavioral-therapy-and-exercise-in-gestational-diabetes-mellitus-gdm-22683https://curecurrent.com/trials/importance-of-meal-fat-content-and-gall-bladder-emptying-for-postprandial-glp-1-secretion-in-type-2-diabetes-patients-22684https://curecurrent.com/trials/bile-acid-induced-glp-secretion-a-study-in-cholecystectomized-subjects-22685https://curecurrent.com/trials/combination-of-olmesartan-and-ccb-or-low-dose-diuretics-in-high-risk-elderly-hypertensive-patients-study-colm-study-22686https://curecurrent.com/trials/modulation-of-free-fatty-acids-in-heart-failure-patients-with-diabetes-effect-on-left-ventricular-function-22687https://curecurrent.com/trials/peripheral-metabolic-effects-of-somatostatin-22688https://curecurrent.com/trials/retinal-venous-pressure-and-et-1-in-patients-with-diabetes-mellitus-22689https://curecurrent.com/trials/metabolic-effects-of-gastrointestinal-surgery-in-t2dm-22690https://curecurrent.com/trials/the-effects-of-weight-loss-on-neuroadrenergic-function-22691https://curecurrent.com/trials/prospective-study-phase-retinal-oxygen-saturation-blood-flow-vascular-function-and-high-resolution-morphometric-imaging-22692https://curecurrent.com/trials/selective-retina-therapy-srt-for-clinically-significant-diabetic-macular-edema-22693https://curecurrent.com/trials/slc2a1-variants-and-diabetic-nephropathy-22694https://curecurrent.com/trials/pathophysiological-implications-of-the-incretin-hormones-in-maturity-onset-of-diabetes-of-the-young-mody-22695https://curecurrent.com/trials/centralised-pan-algerian-survey-on-the-undertreatment-of-hypercholesterolemia-22696https://curecurrent.com/trials/traditional-tibetan-medicine-for-patients-with-coronary-artery-disease-22697https://curecurrent.com/trials/aqueous-flare-of-a-hydrophobic-acrylic-single-piece-open-loop-iol-with-modified-material-surface-properties-22698https://curecurrent.com/trials/effects-of-food-cooking-on-diabetes-2-risk-factors-22699https://curecurrent.com/trials/effect-of-nuts-vs-a-wheat-bran-muffin-in-type-2-diabetes-22700https://curecurrent.com/trials/myo-inositol-d-chiro-inositol-and-d-chiro-myo-inositol-in-gestational-diabetes-22701https://curecurrent.com/trials/comparison-of-a-basal-plus-one-insulin-regimen-with-a-biphasic-insulin-regimen-in-type-2-diabetes-patients-22702https://curecurrent.com/trials/colchicine-for-diabetic-nephropathy-22703https://curecurrent.com/trials/exercise-capability-and-training-effects-in-diabetic-patients-with-neuropathy-22704https://curecurrent.com/trials/a-study-to-efficacy-and-safety-of-cwp-0403-in-type-2-diabetes-mellitus-patients-22705https://curecurrent.com/trials/comparative-study-about-the-influence-of-diabetes-diatress-and-depression-on-treatment-adherence-in-chinese-type-2-diabe-22706https://curecurrent.com/trials/efficacy-of-acarbose-on-intestinal-microbiome-and-incretins-of-type-2-diabetes-22707https://curecurrent.com/trials/effects-of-physical-training-on-heart-rate-variability-and-exercise-capacity-in-diabetes-with-autonomic-neuropathy-22708https://curecurrent.com/trials/intravitreal-long-acting-gas-in-the-prevention-of-early-postoperative-vitreous-hemorrhage-in-diabetic-vitrectomy-22709https://curecurrent.com/trials/a-study-to-evaluate-the-blood-glucose-regulation-and-safety-of-ppb-r-203-02-based-noodle-versus-commercially-available-w-22710https://curecurrent.com/trials/incidence-of-various-types-of-systemic-reactions-related-to-spinal-steroid-injection-a-prospective-study-22711https://curecurrent.com/trials/evaluation-of-block-duration-in-type-2-diabetes-patients-22712https://curecurrent.com/trials/metabolic-changes-in-prostate-cancer-patients-with-androgen-ablation-therapy-aat-22713https://curecurrent.com/trials/optimized-strategy-for-diabetic-patients-with-critical-limb-ischemia-part-ii-dcli-ii-22714https://curecurrent.com/trials/hypothalamic-function-before-and-after-bariatric-surgery-22715https://curecurrent.com/trials/optimized-strategy-for-diabetic-patients-with-critical-limb-ischemia-part-i-22716https://curecurrent.com/trials/a-multicenter-randomized-parallel-group-study-to-investigate-the-efficacy-of-a-combination-of-rosuvastatin-and-fenofibra-22717https://curecurrent.com/trials/copper-study-complications-of-polycystic-ovary-syndrome-pcos-pregnancy-evaluating-risk-22718https://curecurrent.com/trials/comparison-of-xience-prime-versus-resolute-integrity-in-diabetes-or-small-vessel-disease-22719https://curecurrent.com/trials/bioequivalence-study-for-acarbose-metformin-fdc-22720https://curecurrent.com/trials/apidra-children-adolescents-study-22721https://curecurrent.com/trials/safety-and-efficacy-of-galvus-in-elderly-type-2-diabetes-patients-22722https://curecurrent.com/trials/glucose-variability-with-dpp-4-inhibition-22723https://curecurrent.com/trials/study-of-comparing-the-different-effect-of-dpp-4-inhibitors-and-sulfonylurea-by-using-biphase-hyperglycemic-clamp-22724https://curecurrent.com/trials/tailored-antiplatelet-therapy-during-percutaneous-coronary-intervention-in-patients-with-diabetes-mellitus-22725https://curecurrent.com/trials/efficacy-study-of-panax-ginseng-to-boost-antipsychotics-effects-in-schizophrenia-22726https://curecurrent.com/trials/carotid-atherosclerosis-metformin-for-insulin-resistance-study-22727https://curecurrent.com/trials/the-effects-of-exenatide-on-post-meal-sugar-peaks-and-vascular-health-in-obese-pre-diabetic-young-adults-22728https://curecurrent.com/trials/intravitreal-ranibizumab-combined-with-panretinal-photocoagulation-in-patients-with-proliferative-diabetic-retinopathy-22729https://curecurrent.com/trials/effects-of-sitagliptin-on-postprandial-lipemia-in-men-with-type-2-diabetes-22730https://curecurrent.com/trials/hematopoietic-stem-cell-transplantation-in-type-1-diabetes-mellitus-22731https://curecurrent.com/trials/autoimmune-diabetes-markers-of-the-disease-and-treatment-of-latent-autoimmune-diabetes-in-adults-lada-22732https://curecurrent.com/trials/comparison-of-closed-loop-operation-after-morning-meal-with-and-without-carbohydrate-counting-22733https://curecurrent.com/trials/health-effects-of-recreational-soccer-in-type-2-diabetic-men-22734https://curecurrent.com/trials/one-touch-verio-iq-european-clinical-outcomes-study-22735https://curecurrent.com/trials/ramipril-and-clopidogrel-in-oxidative-stress-vascular-inflammation-and-endothelial-dysfunction-in-type-2-diabetes-and-di-22736https://curecurrent.com/trials/hypoglycemia-and-weight-related-quality-of-life-in-patients-with-diabetes-mellitus-type-2-on-sulfonylurea-derivatives-22737https://curecurrent.com/trials/lifestyle-intervention-in-obese-non-diabetic-adults-with-a-family-history-of-diabetes-22738https://curecurrent.com/trials/how-improvement-in-control-of-diabetes-influences-the-production-of-a-hormone-produced-in-the-gut-which-improves-the-rel-22739https://curecurrent.com/trials/combined-nutritional-and-exercise-strategies-to-reduce-liver-fat-content-in-patients-with-type-2-diabetes-22740https://curecurrent.com/trials/japanese-phase-1-multiple-ascending-dose-study-22741https://curecurrent.com/trials/evaluation-of-scout-ds-device-in-the-diagnosis-of-diabetes-mellitus-22742https://curecurrent.com/trials/effect-of-nph-insulin-insulin-detemir-and-insulin-glargine-on-gh-igf-igfbp-axis-22743https://curecurrent.com/trials/lancing-device-comparison-study-22744https://curecurrent.com/trials/the-impact-of-omega-3-supplementation-on-gene-expression-in-type-2-diabetics-22745https://curecurrent.com/trials/biobehavioral-bases-management-of-type-2-diabetes-22746https://curecurrent.com/trials/feasibility-study-of-a-portable-artificial-pancreas-system-in-type-1-diabetes-mellitus-t1dm-montpellier-22747https://curecurrent.com/trials/pilot-study-1-of-outpatient-control-to-range-system-and-monitoring-testing-22748https://curecurrent.com/trials/prospective-observatonal-study-for-effect-of-duodenojejunal-bypass-and-gastric-bypass-on-t2dm-patients-22749https://curecurrent.com/trials/mode-of-action-of-topiramate-in-the-treatment-of-obese-patients-with-and-without-type-2-diabetes-mellitus-22750https://curecurrent.com/trials/lifestyle-intervention-with-an-interactive-video-game-for-type-2-diabetes-patients-22751https://curecurrent.com/trials/type-2-diabetes-mellitus-and-atherosclerosis-22752https://curecurrent.com/trials/nutritional-prevention-pilot-trial-for-type-1-diabetes-22753https://curecurrent.com/trials/safety-and-efficacy-of-aripiprazole-and-ziprasidone-among-schizophrenic-patients-with-metabolic-syndrome-22754https://curecurrent.com/trials/10-prescriptions-an-hour-group-treatment-and-physical-activity-referral-in-a-primary-health-care-setting-22755https://curecurrent.com/trials/comparative-bioavailability-gender-effect-single-and-multiple-ascending-dose-safety-and-pharmacokinetic-study-of-gft505-22756https://curecurrent.com/trials/renal-sympathetic-denervation-as-secondary-prevention-for-patients-after-percutaneous-coronary-intervention-22757https://curecurrent.com/trials/evaluate-efficacy-safety-and-tolerability-of-azd1656-as-add-on-treatment-to-metformin-in-type-2-diabetes-mellitus-td2m-p-22758https://curecurrent.com/trials/health-assessment-patient-treatment-satisfaction-and-quality-of-life-in-insulin-naive-type-2-diabetes-patients-22759https://curecurrent.com/trials/study-to-evaluate-the-effects-of-colesevelam-on-insulin-sensitivity-and-ss-cell-function-in-subjects-with-impaired-fasti-22760https://curecurrent.com/trials/exercise-testing-to-screen-for-unknown-coronary-artery-disease-in-diabetic-patients-does-it-contribute-to-a-risk-reducti-22761https://curecurrent.com/trials/arterial-wall-calcium-load-in-pseudoxanthoma-elasticum-22762https://curecurrent.com/trials/assessing-continuous-non-invasive-blood-glucose-sensor-physical-logic-ag-22763https://curecurrent.com/trials/diacon-overnight-closed-loop-glucose-control-study-22764https://curecurrent.com/trials/umbilical-mesenchymal-stem-cells-and-mononuclear-cells-infusion-in-type-1-diabetes-mellitus-22765https://curecurrent.com/trials/evaluation-of-effects-of-exercise-training-and-arb-in-dm-patients-22766https://curecurrent.com/trials/resistance-training-in-diabetic-elder-patients-22767https://curecurrent.com/trials/adalat-xl-vs-diltiazem-on-proteinuria-and-blood-pressure-in-hypertensive-diabetic-patients-22768https://curecurrent.com/trials/improvement-of-a-physically-active-lifestyle-22769https://curecurrent.com/trials/stage-based-exercise-promotion-study-22770https://curecurrent.com/trials/increasing-vitamin-intake-and-physical-activity-22771https://curecurrent.com/trials/online-program-assisting-lifestyle-changes-asterix-1-0-obelix-2-0-22772https://curecurrent.com/trials/achieving-normal-glucose-in-hospital-settings-22773https://curecurrent.com/trials/study-of-tak-559-in-treating-subjects-with-type-2-diabetes-mellitus-22774https://curecurrent.com/trials/efficacy-and-safety-study-of-tak-559-in-treating-subjects-with-type-2-diabetes-mellitus-22775https://curecurrent.com/trials/safety-study-of-tak-559-in-treating-subjects-with-type-2-diabetes-mellitus-22776https://curecurrent.com/trials/efficacy-of-tak-559-in-treating-subjects-with-type-2-diabetes-mellitus-22777https://curecurrent.com/trials/a-clinical-trial-to-study-the-effects-of-grc-17536-in-patients-with-painful-diabetic-neuropathy-painful-extremities-due-22778https://curecurrent.com/trials/prevention-of-renal-complications-of-diabetes-with-thiamine-22779https://curecurrent.com/trials/beneficial-effects-of-korean-traditional-diets-in-subjects-with-hypertension-and-type-2-diabetes-22780https://curecurrent.com/trials/double-blind-comparative-study-of-tak-875-22781https://curecurrent.com/trials/effect-of-taurine-on-glycemic-control-in-type-i-and-type-ii-diabetic-patients-22782https://curecurrent.com/trials/jordan-diabetes-microclinic-project-22783https://curecurrent.com/trials/efficacy-and-safety-of-alprostadil-prevent-contrast-induced-nephropathy-22784https://curecurrent.com/trials/safety-and-efficacy-of-mecobalamin-injection-in-peripheral-neuropathies-patients-study-jgazsy091109-22785https://curecurrent.com/trials/clinical-trial-for-the-treatment-of-diabetic-foot-ulcers-using-a-nitric-oxide-releasing-patch-pathon-22786https://curecurrent.com/trials/diabetic-retinopathy-sulodexide-study-22787https://curecurrent.com/trials/diagnosis-and-therapy-of-vulnerable-atherosclerotic-plaque-22788https://curecurrent.com/trials/metabolic-effects-of-treatment-in-patients-with-recently-diagnosed-type-2-diabetes-22789https://curecurrent.com/trials/nitrate-and-exercise-induced-cardiac-troponin-t-in-type-2-diabetes-22790https://curecurrent.com/trials/weight-gain-eating-patterns-and-development-of-body-composition-during-initiation-of-basal-insulin-therapy-in-patients-w-22791https://curecurrent.com/trials/ss-cell-function-and-glycemic-control-in-newly-diagnosed-type-2-diabetic-patients-with-moderate-hyperglycemia-22792https://curecurrent.com/trials/neurotrophic-factors-in-cerebrospinal-fluid-in-diabetic-patients-with-polyneuropathy-22793https://curecurrent.com/trials/tolvaptan-for-hyponatremia-in-cirrhotic-patients-with-ascites-22794https://curecurrent.com/trials/a-clinical-safety-and-efficacy-comparison-of-nevanac-0-1-to-vehicle-after-cataract-surgery-in-diabetic-retinopathy-patie-22795https://curecurrent.com/trials/effect-of-different-plasma-insulin-levels-on-the-accuracy-of-continuous-subcutaneous-glucose-monitoring-22796https://curecurrent.com/trials/exercise-and-glycemic-control-in-type-2-diabetes-22797https://curecurrent.com/trials/mobile-phone-applications-and-quality-of-life-22798https://curecurrent.com/trials/use-of-computers-to-prevent-metabolic-syndrome-22799https://curecurrent.com/trials/device-guided-breathing-exercises-on-blood-pressure-in-diabetic-patients-22800https://curecurrent.com/trials/be-study-of-metformin-gsk-850mg-22801https://curecurrent.com/trials/effects-of-nateglinide-on-postprandial-glucose-excursion-by-restoring-early-phase-insulin-secretion-22802https://curecurrent.com/trials/be-study-of-metformin-gsk-1000mg-22803https://curecurrent.com/trials/dpp-iv-inhibitors-underlying-mechanism-of-cancer-in-diabetic-patients-22804https://curecurrent.com/trials/the-effects-of-soy-isoflavones-to-improve-the-metabolism-of-glucose-and-lipids-22805https://curecurrent.com/trials/nir-and-multifrequent-impedance-spectroscopy-on-the-skin-in-type-1-diabetes-22806https://curecurrent.com/trials/the-relationship-between-vascular-adhesion-protein-1-and-diabetic-cardiovascular-autonomic-neuropathy-22807https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-brl-49653c-in-non-insulin-dependent-diabetes-22808https://curecurrent.com/trials/regulation-of-tissue-lipolysis-by-insulin-in-type-2-diabetes-22809https://curecurrent.com/trials/prevention-of-contrast-induced-nephropathy-by-erythropoietin-22810https://curecurrent.com/trials/vitamin-d-supplementation-and-regulatory-foxp3-t-cells-in-the-gut-22811https://curecurrent.com/trials/adding-sitagliptin-or-pioglitazone-to-type-2-diabetes-mellitus-insufficiently-controlled-with-metformin-and-sulfonylurea-22812https://curecurrent.com/trials/vitamin-d-inadequacy-is-associated-with-incidence-of-type-2-diabetes-22813https://curecurrent.com/trials/fgf-23-and-endothelial-dysfunction-in-diabetic-proteinuric-patients-22814https://curecurrent.com/trials/the-acute-effect-of-malt-extract-versus-sucrose-on-the-response-of-glucose-and-insulin-subjective-appetite-sensations-an-22815https://curecurrent.com/trials/impact-of-objective-sleep-duration-on-blood-glucose-control-in-type-1-diabetes-adult-patients-22816https://curecurrent.com/trials/activity-and-metformin-intervention-in-obese-adolescents-22817https://curecurrent.com/trials/physical-and-chemical-study-of-atherosclerosis-mechanisms-22818https://curecurrent.com/trials/health2006-an-observational-study-of-cardiovascular-disease-diabetes-asthma-and-allergy-22819https://curecurrent.com/trials/lifestyle-intervention-in-a-general-population-for-prevention-of-ischaemic-heart-disease-22820https://curecurrent.com/trials/reduction-of-plantar-pressure-in-neuropathic-diabetic-foot-patients-using-insoles-with-removable-pegs-design-22821https://curecurrent.com/trials/the-effect-of-a-lipoic-acid-ala-on-fatty-acid-induced-impairment-of-glucose-stimulated-insulin-secretion-22822https://curecurrent.com/trials/dose-ranging-study-of-the-effects-of-alpha-lipoic-acid-on-oxidative-stress-22823https://curecurrent.com/trials/tissue-distribution-of-f18-fdg-labelled-autologous-bone-marrow-derived-stem-cells-in-patients-with-type-2-dm-22824https://curecurrent.com/trials/anti-inflammatory-effects-of-pioglitazone-22825https://curecurrent.com/trials/combined-triple-therapy-in-diabetic-retinopathy-drp-22826https://curecurrent.com/trials/interventions-to-prevent-adolescents-with-type-1-diabetes-from-long-term-complications-22827https://curecurrent.com/trials/vildagliptin-and-the-glucagon-response-to-hypoglycemia-in-type-1-diabetes-22828https://curecurrent.com/trials/identification-of-the-region-of-vitamin-d-responsiveness-22829https://curecurrent.com/trials/sitagliptin-in-renal-transplant-recipients-22830https://curecurrent.com/trials/effects-of-antioxidants-and-b-vitamins-supplements-on-inflammation-in-obese-diabetic-patients-22831https://curecurrent.com/trials/bromelain-and-cardiovascular-risk-factors-in-diabetes-22832https://curecurrent.com/trials/pilot-study-with-gft505-80mg-in-patients-with-insulin-resistance-and-abdominal-obesity-22833https://curecurrent.com/trials/quantification-of-rising-the-osmotic-pressure-in-diabetic-intraretinal-fluid-accumulation-diabetic-macular-oedema-22834https://curecurrent.com/trials/endothelial-and-metabolic-effects-of-glucagon-like-peptide-1-glp-1-in-coronary-circulation-in-patients-with-type-2-diabe-22835https://curecurrent.com/trials/the-metabolic-effects-of-acute-hyperglycemia-in-patients-with-type-2-diabetes-22836https://curecurrent.com/trials/effect-of-pharmacological-anti-lipolysis-on-ffa-and-vldl-tg-metabolism-before-and-during-exercise-22837https://curecurrent.com/trials/a-randomized-controlled-trial-comparing-medical-and-medical-surgical-treatment-in-diabetic-foot-osteomyelitis-22838https://curecurrent.com/trials/pharmaceutical-care-of-ambulatory-elderly-diabetes-patients-22839https://curecurrent.com/trials/effect-of-genistein-in-women-with-metabolic-syndrome-22840https://curecurrent.com/trials/evaluation-of-the-effects-of-heating-the-vicinity-of-the-insulin-delivery-site-by-the-insupatch-device-during-daily-life-22841https://curecurrent.com/trials/improving-diabetes-by-reconstruction-methods-in-gastric-cancer-patients-with-diabetes-mellitus-22842https://curecurrent.com/trials/normalization-of-fasting-glucose-and-the-incidence-of-restenosis-after-peripheral-angioplasty-22843https://curecurrent.com/trials/metabolic-activation-with-almased-for-type-2-diabetes-patients-22844https://curecurrent.com/trials/a-cohort-study-of-incretin-based-therapy-combined-with-insulin-in-type-2-diabetic-patients-for-5-years-22845https://curecurrent.com/trials/polydeoxyribonucleotide-placentex-mastelli-pdrn-for-the-treatment-of-diabetic-ulcers-22846https://curecurrent.com/trials/study-of-maggot-therapy-in-diabetic-foot-ulcers-22847https://curecurrent.com/trials/nutritional-intervention-with-moderately-high-protein-low-glycemic-load-products-in-type-2-diabetes-patients-22848https://curecurrent.com/trials/clinical-and-pathophysiological-description-of-ocular-ischemic-syndrome-22849https://curecurrent.com/trials/safety-and-efficacy-study-of-herbal-supplements-in-prediabetic-and-mild-to-moderate-hyperlipidemic-patients-22850https://curecurrent.com/trials/ileal-interposition-with-sleeve-gastrectomy-for-control-of-diabetes-22851https://curecurrent.com/trials/patient-based-strategy-to-reduce-errors-in-diabetes-care-22852https://curecurrent.com/trials/vitamin-d-and-staphylococcus-aureus-in-the-diabetes-study-22853https://curecurrent.com/trials/effects-of-advanced-glycation-endproducts-on-satiety-and-inflammation-22854https://curecurrent.com/trials/pilot-study-to-evaluate-magnetic-marker-imaging-on-diabetic-polyneuropathy-and-gastroparesis-22855https://curecurrent.com/trials/insulin-analogues-and-severe-hypoglycaemia-22856https://curecurrent.com/trials/the-effect-of-nexium-and-probiotics-on-insulin-secretion-and-cardiovascular-risk-factors-in-patients-with-type-2-diabete-22857https://curecurrent.com/trials/effects-of-resveratrol-in-patients-with-type-2-diabetes-22858https://curecurrent.com/trials/safety-and-efficacy-of-long-limb-roux-en-y-reconstruction-22859https://curecurrent.com/trials/anti-interleukin-1-in-diabetes-action-22860https://curecurrent.com/trials/bolus-calculator-and-wireless-communication-with-blood-glucose-meter-in-management-of-type-1-diabetes-mellitus-t1dm-22861https://curecurrent.com/trials/applications-site-reactions-after-injection-of-insulin-detemir-and-saline-in-subjects-with-diabetes-22862https://curecurrent.com/trials/fit-for-kids-copenhagen-22863https://curecurrent.com/trials/intensive-insulin-glulisine-therapy-in-patients-with-type-2-diabetes-inadequately-controlled-with-basal-insulin-and-oral-22864https://curecurrent.com/trials/new-strategies-for-postprandial-glycemic-control-using-insulin-pump-therapy-22865https://curecurrent.com/trials/effects-of-spironolactone-combination-therapy-on-proteinuria-kidney-function-and-blood-pressure-22866https://curecurrent.com/trials/japan-dose-regimen-study-of-azd1656-in-japanese-type-2-diabetes-mellitus-patients-22867https://curecurrent.com/trials/compare-the-compliance-of-patients-treated-with-once-daily-od-or-twice-daily-bid-glimepiride-and-metformin-fixed-combina-22868https://curecurrent.com/trials/effect-of-low-glycaemic-index-diet-on-blood-glucose-control-in-chinese-type-2-diabetic-patients-22869https://curecurrent.com/trials/galvus-on-met-phase-4-study-study-to-evaluate-the-efficacy-and-safety-of-early-combination-of-vildagliptin-and-metformin-22870https://curecurrent.com/trials/the-association-between-monocyte-subsets-and-coronary-collateral-development-in-diabetes-mellitus-22871https://curecurrent.com/trials/mechanisms-of-glucose-counterregulation-in-pancreatic-islet-transplantation-22872https://curecurrent.com/trials/lantus-versus-nph-comparison-in-insulin-naive-people-not-adequately-controlled-with-at-least-one-oral-anti-diabetics-oad-22873https://curecurrent.com/trials/a-study-on-traditional-chinese-medicine-tcm-comprehensive-protocol-of-prevention-and-control-in-diabetic-retinopathy-22874https://curecurrent.com/trials/treatment-with-sitagliptin-in-non-obese-japanese-patients-with-type-2-diabetes-mellitus-22875https://curecurrent.com/trials/a-practice-nurse-addressed-intervention-to-improve-type-2-diabetes-care-22876https://curecurrent.com/trials/a-pk-pd-study-of-psn821-in-type-2-diabetes-patients-t2dm-22877https://curecurrent.com/trials/long-term-safety-study-of-alogliptin-used-in-combination-with-sulfonylurea-or-metformin-in-participants-with-type-2-diab-22878https://curecurrent.com/trials/effects-of-genistein-in-postmenopausal-women-with-metabolic-syndrome-22879https://curecurrent.com/trials/the-effects-of-insulin-detemir-and-gliclazide-mr-treatments-on-endothelial-functions-in-patients-with-type-2-diabetes-22880https://curecurrent.com/trials/effects-of-vitamin-d-and-calcium-supplementation-on-inflammatory-biomarkers-and-adypocytokines-in-diabetic-patients-22881https://curecurrent.com/trials/a-study-of-minirin-melt-in-japanese-patients-with-central-diabetes-insipidus-cdi-22882https://curecurrent.com/trials/safety-study-of-intranasal-insulin-in-type-1-diabetes-and-diabetic-peripheral-neuropathy-22883https://curecurrent.com/trials/saxagliptin-triple-oral-therapy-22884https://curecurrent.com/trials/diabetes-prevention-in-prediabetic-patients-22885https://curecurrent.com/trials/evaluation-of-intermediate-care-clinics-for-diabetes-22886https://curecurrent.com/trials/efficacy-and-safety-of-glimepiride-as-oral-anti-diabetic-oad-initiation-mono-therapy-in-chinese-type-2-diabetes-mellitus-22887https://curecurrent.com/trials/effect-of-fish-oil-on-insulin-sensitivity-22888https://curecurrent.com/trials/efficacy-and-safety-of-dlbs3233-in-prediabetic-patients-22889https://curecurrent.com/trials/practice-based-nutrition-intervention-22890https://curecurrent.com/trials/effect-of-flavanol-rich-cocoa-on-peripheral-and-cerebral-blood-flow-in-type-2-diabetes-22891https://curecurrent.com/trials/a-study-on-the-effects-of-ranolazine-on-exercise-duration-in-subjects-with-chronic-stable-angina-and-coronary-artery-dis-22892https://curecurrent.com/trials/peking-and-rotterdam-on-mission-to-reduce-coronary-artery-disease-22893https://curecurrent.com/trials/multi-day-3-in-patient-evaluation-of-intradermal-versus-subcutaneous-basal-and-bolus-insulin-infusion-22894https://curecurrent.com/trials/intensity-of-exercise-and-glucose-metabolism-22895https://curecurrent.com/trials/longitudinal-measures-of-leptin-in-pregnant-women-who-developed-preeclampsia-22896https://curecurrent.com/trials/safety-and-efficacy-of-insulin-aspart-in-type-2-diabetes-22897https://curecurrent.com/trials/neurovascular-coupling-in-patients-with-early-stage-diabetes-retinopathy-22898https://curecurrent.com/trials/impact-of-acarbose-on-abnormal-glucose-regulation-in-patients-with-coronary-artery-disease-aaa-trial-22899https://curecurrent.com/trials/clinical-trial-to-evaluate-the-efficacy-and-safety-of-the-use-of-ozone-versus-sunflower-oil-in-treating-diabetic-foot-22900https://curecurrent.com/trials/test-of-the-efficacy-and-safety-of-insulin-glulisine-injected-subcutaneously-in-patients-with-type-1-diabetes-mellitus-22901https://curecurrent.com/trials/insulin-glargine-lantus-vs-sulfonylurea-su-for-beta-cell-function-beta-study-22902https://curecurrent.com/trials/complementary-and-integrative-therapy-for-diabetic-neuropathy-22903https://curecurrent.com/trials/long-term-effects-of-gestational-diabetes-mellitus-in-a-population-of-parous-women-22904https://curecurrent.com/trials/propofol-cardioprotection-for-type-ii-diabetics-22905https://curecurrent.com/trials/a-randomized-clinical-trial-of-megestrol-acetate-as-an-appetite-stimulant-in-malnourished-children-with-cancer-22906https://curecurrent.com/trials/alemtuzumab-induction-in-islet-transplantation-22907https://curecurrent.com/trials/dextromethorphan-amantadine-and-glucose-homeostasis-in-diabetes-subjects-22908https://curecurrent.com/trials/skin-samples-of-diabetic-patients-and-healthy-volunteers-collection-22909https://curecurrent.com/trials/effect-of-pioglitazone-on-ambulatory-blood-pressure-22910https://curecurrent.com/trials/early-diagnosis-of-diabetes-mellitus-in-patients-with-cystic-fibrosis-22911https://curecurrent.com/trials/the-effects-of-hypolipemic-and-antidiabetic-treatment-on-cytokines-22912https://curecurrent.com/trials/role-of-nutrition-and-maternal-genetics-on-the-programming-of-development-of-fetal-adipose-tissue-22913https://curecurrent.com/trials/evaluation-of-scout-ds-device-in-the-diagnosis-of-diabetes-22914https://curecurrent.com/trials/multicentre-study-to-investigate-the-performance-of-the-padd-device-in-the-assessment-of-peripheral-arterial-disease-22915https://curecurrent.com/trials/endothelial-dysfunction-and-diabetes-22916https://curecurrent.com/trials/safety-acceptability-and-efficacy-of-a-long-term-intervention-with-a-diabetes-specific-low-carbohydrate-high-mono-unsatu-22917https://curecurrent.com/trials/sitagliptin-prophylaxis-for-glucocorticoid-induced-impairment-of-glucose-metabolism-in-males-with-the-metabolic-syndrome-22918https://curecurrent.com/trials/frequency-modulated-neural-stimulation-frems-in-symptomatic-diabetic-neuropathy-22919https://curecurrent.com/trials/closing-the-loop-in-adolescents-during-non-compliance-behaviours-22920https://curecurrent.com/trials/closing-the-loop-for-36-hours-in-adolescents-with-type-1-diabetes-evaluation-of-reduced-meal-bolusing-22921https://curecurrent.com/trials/the-cost-effectiveness-of-screening-for-diabetic-retinopathy-in-hong-kong-22922https://curecurrent.com/trials/adolescent-fitness-assessment-program-22923https://curecurrent.com/trials/automated-overnight-closed-loop-glucose-control-in-young-people-with-type-1-diabetes-22924https://curecurrent.com/trials/comparison-of-two-insulin-regimens-in-optimally-controlled-patients-with-dm2-22925https://curecurrent.com/trials/evaluating-the-renoprotective-effect-of-milk-thistle-extract-on-patients-with-type-ii-diabetic-nephropathy-22926https://curecurrent.com/trials/endothelial-function-as-a-marker-for-blood-pressure-control-among-hypertensive-diabetic-patients-22927https://curecurrent.com/trials/comparison-of-hypoglycaemic-regimens-during-ramadan-fasting-in-type-2-diabetes-22928https://curecurrent.com/trials/the-effect-of-rosuvastatin-in-diabetic-polyneuropathy-a-phase-iia-randomized-double-blind-placebo-controlled-study-22929https://curecurrent.com/trials/effect-of-ezetimibe-or-simvastatin-or-both-on-low-densitiy-lipoprotein-subfractions-in-patients-with-type-2-diabetes-22930https://curecurrent.com/trials/nitric-oxide-no-activity-and-diabetic-nephropathy-22931https://curecurrent.com/trials/an-investigation-into-bone-micro-architecture-in-women-with-type-2-diabetes-22932https://curecurrent.com/trials/glibenclamide-dose-to-be-titrated-from-starting-dose-of-5mg-om-plus-rosiglitazone-4mg-om-increased-to-8mg-om-after-6-mon-22933https://curecurrent.com/trials/effect-of-consuming-beans-for-one-month-on-blood-lipids-satiety-intake-regulation-and-body-weight-22934https://curecurrent.com/trials/yellow-pea-protein-and-fibre-and-short-term-food-intake-22935https://curecurrent.com/trials/yellow-pea-fractions-and-short-term-food-intake-subjective-appetite-and-glycemic-response-22936https://curecurrent.com/trials/controlled-study-of-mk-0431-ono-5435-in-patients-with-type-2-diabetes-mellitus-22937https://curecurrent.com/trials/controlled-study-of-mk-0431-ono-5435-in-patients-with-type-2-diabetes-mellitus-22938https://curecurrent.com/trials/mk-0431-ono-5435-phase-iii-clinical-trial-insulin-add-on-study-for-patients-with-type-2-diabetes-mellitus-22939https://curecurrent.com/trials/isovolumetric-and-isocaloric-preloads-of-various-types-of-milk-on-food-intake-subjective-appetite-and-glycemic-response-22940https://curecurrent.com/trials/a-first-in-human-single-dose-safety-and-tolerability-study-of-mkc253-inhalation-powder-in-healthy-adult-males-22941https://curecurrent.com/trials/a-study-designed-to-determine-the-safety-and-pharmacological-response-ofmkc253-inhalation-powder-in-adults-with-type-2-d-22942https://curecurrent.com/trials/a-study-designed-to-determine-if-the-pharmacokinetic-disposition-of-inhaled-insulin-exposure-is-the-same-for-asthmatics-22943https://curecurrent.com/trials/a-study-designed-to-determine-if-the-drugs-albuterol-salbutamol-and-fluticasone-have-an-effect-on-the-pharmacokinetics-o-22944https://curecurrent.com/trials/pilot-study-of-ono-5129-in-patients-with-type-2-diabetes-mellitus-22945https://curecurrent.com/trials/controlled-study-of-mk-0431-ono-5435-in-patients-with-type-2-diabetes-mellitus-22946https://curecurrent.com/trials/validating-non-invasive-measurements-of-central-blood-pressure-in-type-2-diabetic-patients-22947https://curecurrent.com/trials/glycemic-response-to-momordica-charantia-in-type-2-diabetes-22948https://curecurrent.com/trials/aspirin-twice-daily-in-diabetic-patients-with-coronary-artery-disease-22949https://curecurrent.com/trials/human-menstrual-blood-derived-mesenchymal-stem-cells-transplantation-in-treating-type-1-diabetic-patients-22950https://curecurrent.com/trials/role-of-pioglitazone-and-berberine-in-treatment-of-non-alcoholic-fatty-liver-disease-22951https://curecurrent.com/trials/treatment-satisfaction-of-insulin-glargine-plus-insulin-apidra-compared-with-nph-insulin-plus-insulin-apidra-in-recently-22952https://curecurrent.com/trials/the-glycemic-response-elicited-by-beta-glucans-of-different-physical-properties-and-form-22953https://curecurrent.com/trials/in-patient-study-in-patients-with-type-2-diabetes-mellitus-22954https://curecurrent.com/trials/screening-epidemiological-program-on-compensation-evaluation-of-diabetes-mellitus-type-2-dmt2-patients-on-oral-anti-diab-22955https://curecurrent.com/trials/drug-interactions-from-simultaneous-administration-of-metformin-and-gsk189075-to-subjects-with-type-2-diabetes-22956https://curecurrent.com/trials/a-study-of-rosiglitazone-plus-insulin-to-treat-type-2-diabetes-mellitus-patients-22957https://curecurrent.com/trials/a-study-on-the-effect-of-2-pen-devices-on-hba1c-22958https://curecurrent.com/trials/impact-of-liraglutide-on-sensory-perception-sensory-specific-satiety-liking-and-wanting-in-type-2-diabetic-patients-22959https://curecurrent.com/trials/a-study-to-to-assess-the-effect-of-dapagliflozin-when-administered-once-a-day-versus-twice-a-day-on-blood-glucose-22960https://curecurrent.com/trials/study-to-assess-the-effect-of-food-on-combination-dapagliflozin-metformin-tablet-in-healthy-volunteers-22961https://curecurrent.com/trials/eplerenone-ace-inhibition-and-albuminuria-22962https://curecurrent.com/trials/effect-of-dipeptidyl-peptidase-iv-after-diets-in-n-ive-type-2-diabetic-patients-22963https://curecurrent.com/trials/a-first-in-human-study-of-ly2409021-in-healthy-participants-and-participants-with-type-2-diabetes-22964https://curecurrent.com/trials/induced-wound-healing-by-application-of-expanded-bone-marrow-stem-cells-in-diabetic-patients-with-critical-limb-ischemia-22965https://curecurrent.com/trials/a-study-of-multiple-increasing-doses-of-ly2409021-in-participants-with-type-2-diabetes-22966https://curecurrent.com/trials/a-lifestyle-and-combination-medication-therapy-diabetes-prevention-study-22967https://curecurrent.com/trials/diabetes-risk-evaluation-and-management-tele-monitoring-study-dream-tel-22968https://curecurrent.com/trials/efficacy-and-safety-study-of-syr-619-in-treating-subjects-with-type-2-diabetes-mellitus-22969https://curecurrent.com/trials/safety-and-tolerability-of-pioglitazone-azilsartan-in-subjects-with-type-2-diabetes-22970https://curecurrent.com/trials/phase-3-trial-to-evaluate-the-efficacy-and-safety-of-lc15-0444-in-patients-with-type-2-diabetes-22971https://curecurrent.com/trials/phase-iii-trial-to-evaluate-the-efficacy-and-safety-of-lc15-0444-compared-with-sitagliptin-added-to-ongoing-metformin-th-22972https://curecurrent.com/trials/hair-cortisol-and-testosterone-levels-in-patients-with-and-without-acute-myocardial-infarction-mi-22973https://curecurrent.com/trials/study-of-the-safety-and-biologic-activity-of-xoma-052-in-subjects-with-type-2-diabetes-mellitus-22974https://curecurrent.com/trials/diabetes-risk-evaluation-and-microalbuminuria-in-saskatchewan-first-nations-peoples-22975https://curecurrent.com/trials/identifying-therapeutic-factors-in-an-8-week-30-hour-mindfulness-based-stress-reduction-mbsr-program-22976https://curecurrent.com/trials/improving-the-management-of-obesity-in-primary-care-practice-the-power-up-trial-22977https://curecurrent.com/trials/a-retrospective-study-of-cardiovascular-events-related-to-the-use-of-glucose-lowering-drug-treatment-in-primary-care-22978https://curecurrent.com/trials/postprandial-insulin-secretion-oxidative-stress-and-gastrointestinal-peptides-in-patients-with-type-2-diabetes-versus-he-22979https://curecurrent.com/trials/randomized-double-blind-placebo-controlled-study-to-evaluate-the-effect-of-roflumilast-on-endothelial-function-in-patien-22980https://curecurrent.com/trials/effects-of-nateglinide-vs-acarbose-on-postprandial-glucose-fluctuation-dyslipidemia-and-inflammatory-factors-22981https://curecurrent.com/trials/the-clinical-and-economic-impacts-of-e-heath-on-diabetes-22982https://curecurrent.com/trials/comparison-of-metformin-and-pioglitazone-effects-on-adipokines-concentrations-in-newly-diagnosed-type-2-diabetes-patient-22983https://curecurrent.com/trials/the-effect-of-real-time-continuous-glucose-monitoring-on-severe-complications-to-pregnancy-in-women-with-diabetes-22984https://curecurrent.com/trials/efficacy-and-safety-study-of-topical-capsaicin-in-painful-diabetic-neuropathy-22985https://curecurrent.com/trials/trial-of-different-dosages-ge-gen-qin-lian-decoction-in-the-treatment-of-type-2-diabetes-22986https://curecurrent.com/trials/healing-profile-of-titanium-dental-implants-placed-in-patients-with-diabetes-22987https://curecurrent.com/trials/treatment-satisfaction-of-using-omnipod-system-compared-with-conventional-insulin-pump-in-adults-with-type-1-diabetes-22988https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-in-combination-with-insulin-in-patients-with-type-2-diabetes-22989https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-compared-to-metformin-in-drug-naive-patients-with-type-2-diabetes-22990https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-in-patients-with-type-2-diabetes-with-hba1c-9-11-22991https://curecurrent.com/trials/a-study-to-assess-the-effects-of-dpp-4-inhibition-on-insulin-sensitivity-in-type-2-diabetes-22992https://curecurrent.com/trials/multiple-ascending-dose-trial-of-byk324677-in-healthy-volunteers-22993https://curecurrent.com/trials/a-lifestyle-change-program-to-prevent-type-2-diabetes-22994https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-compared-to-placebo-in-patients-with-type-2-diabetes-and-mild-hyperglycemia-22995https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-vildagliptin-on-the-maximum-insulin-secretion-in-patients-with-type-2-diabetes-22996https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-compared-to-acarbose-in-drug-naive-patients-with-type-2-diabetes-22997https://curecurrent.com/trials/influence-of-different-approaches-to-dietary-advising-on-the-effects-of-acarbose-treatment-in-obese-diabetic-patients-un-22998https://curecurrent.com/trials/glycemic-holter-study-continuous-glucose-monitoring-22999https://curecurrent.com/trials/nt-probnp-guided-primary-prevention-of-cv-events-in-diabetic-patients-23000